UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-CSR

 

CERTIFIED SHAREHOLDER REPORT

OF

REGISTERED MANAGEMENT INVESTMENT COMPANIES

 

Investment Company Act file number: 811-03916

 

Name of Registrant: Vanguard Specialized Funds
Address of Registrant: P.O. Box 2600
  Valley Forge, PA 19482

 

Name and address of agent for service: Natalie Lamarque, Esquire
  P.O. Box 876
  Valley Forge, PA 19482

 

Registrant’s telephone number, including area code: (610) 669-1000

 

Date of fiscal year end: January 31

 

Date of reporting period: February 1, 2025—January 31, 2026

 

 

 

 

 

 

 

Item 1: Reports to Shareholders.

 

 

 

 

TABLE OF CONTENTS

Dividend Growth Fund
Investor Shares - VDIGX

Energy Fund
Investor Shares - VGENX

Energy Fund
Admiral™ Shares - VGELX

Health Care Fund
Investor Shares - VGHCX

Health Care Fund
Admiral™ Shares - VGHAX

Dividend Appreciation Index Fund
ETF Shares - VIG

Dividend Appreciation Index Fund
Admiral™ Shares - VDADX

0000734383falseN-1A0000734383nacc2:C000008004Member2025-02-012026-01-3100007343832025-02-012026-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000008004Member2016-01-312016-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000008004Member2016-02-012016-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000008004Member2016-02-012016-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000008004Member2016-02-012016-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000008004Member2016-02-012017-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000008004Member2016-02-012017-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000008004Member2016-02-012017-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000008004Member2016-02-012017-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000008004Member2016-02-012018-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000008004Member2016-02-012018-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000008004Member2016-02-012018-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000008004Member2016-02-012018-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000008004Member2016-02-012019-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000008004Member2016-02-012019-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000008004Member2016-02-012019-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000008004Member2016-02-012019-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000008004Member2016-02-012020-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000008004Member2016-02-012020-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000008004Member2016-02-012020-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000008004Member2016-02-012020-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000008004Member2016-02-012021-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000008004Member2016-02-012021-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000008004Member2016-02-012021-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000008004Member2016-02-012021-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000008004Member2016-02-012022-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000008004Member2016-02-012022-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000008004Member2016-02-012022-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000008004Member2016-02-012022-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000008004Member2016-02-012023-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000008004Member2016-02-012023-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000008004Member2016-02-012023-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000008004Member2016-02-012023-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000008004Member2016-02-012024-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000008004Member2016-02-012024-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000008004Member2016-02-012024-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000008004Member2016-02-012024-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000008004Member2016-02-012025-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000008004Member2016-02-012025-04-300000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000008004Member2016-02-012025-07-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000008004Member2016-02-012025-10-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000008004Member2016-02-012026-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000008004Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000008004Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000008004Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexDividendGrowthSplicedIndex17467AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17467BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000008004Member2026-01-310000734383nacc2:C000008004Membernacc2:SectorCommunicationServicesSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorConsumerDiscretionarySectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorConsumerStaplesSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorFinancialsSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorHealthCareSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorIndustrialsSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorInformationTechnologySectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorMaterialsSectorMember2026-01-310000734383nacc2:C000008004Membernacc2:SectorOtherNetLineSectorMember2026-01-310000734383nacc2:C000008004Member2024-02-012025-01-310000734383nacc2:C000008005Member2025-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000008005Member2016-01-312016-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000008005Member2016-02-012016-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000008005Member2016-02-012016-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000008005Member2016-02-012016-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000008005Member2016-02-012017-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000008005Member2016-02-012017-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000008005Member2016-02-012017-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000008005Member2016-02-012017-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000008005Member2016-02-012018-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000008005Member2016-02-012018-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000008005Member2016-02-012018-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000008005Member2016-02-012018-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000008005Member2016-02-012019-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000008005Member2016-02-012019-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000008005Member2016-02-012019-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000008005Member2016-02-012019-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000008005Member2016-02-012020-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000008005Member2016-02-012020-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000008005Member2016-02-012020-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000008005Member2016-02-012020-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000008005Member2016-02-012021-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000008005Member2016-02-012021-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000008005Member2016-02-012021-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000008005Member2016-02-012021-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000008005Member2016-02-012022-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000008005Member2016-02-012022-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000008005Member2016-02-012022-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000008005Member2016-02-012022-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000008005Member2016-02-012023-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000008005Member2016-02-012023-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000008005Member2016-02-012023-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000008005Member2016-02-012023-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000008005Member2016-02-012024-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000008005Member2016-02-012024-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000008005Member2016-02-012024-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000008005Member2016-02-012024-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000008005Member2016-02-012025-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000008005Member2016-02-012025-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000008005Member2016-02-012025-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000008005Member2016-02-012025-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000008005Member2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000008005Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000008005Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000008005Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17470AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17470BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000008005Member2026-01-310000734383nacc2:C000008005Membernacc2:AsiaCTIMember2026-01-310000734383nacc2:C000008005Membernacc2:EuropeCTIMember2026-01-310000734383nacc2:C000008005Membernacc2:NorthAmericaCTIMember2026-01-310000734383nacc2:C000008005Membernacc2:SouthAmericaCTIMember2026-01-310000734383nacc2:C000008005Membernacc2:CountryOtherNetLineCTIMember2026-01-310000734383nacc2:C000008005Member2024-02-012025-01-310000734383nacc2:C000008006Member2025-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000008006Member2016-01-312016-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000008006Member2016-02-012016-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000008006Member2016-02-012016-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000008006Member2016-02-012016-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000008006Member2016-02-012017-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000008006Member2016-02-012017-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000008006Member2016-02-012017-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000008006Member2016-02-012017-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000008006Member2016-02-012018-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000008006Member2016-02-012018-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000008006Member2016-02-012018-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000008006Member2016-02-012018-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000008006Member2016-02-012019-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000008006Member2016-02-012019-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000008006Member2016-02-012019-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000008006Member2016-02-012019-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000008006Member2016-02-012020-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000008006Member2016-02-012020-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000008006Member2016-02-012020-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000008006Member2016-02-012020-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000008006Member2016-02-012021-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000008006Member2016-02-012021-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000008006Member2016-02-012021-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000008006Member2016-02-012021-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000008006Member2016-02-012022-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000008006Member2016-02-012022-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000008006Member2016-02-012022-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000008006Member2016-02-012022-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000008006Member2016-02-012023-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000008006Member2016-02-012023-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000008006Member2016-02-012023-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000008006Member2016-02-012023-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000008006Member2016-02-012024-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000008006Member2016-02-012024-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000008006Member2016-02-012024-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000008006Member2016-02-012024-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000008006Member2016-02-012025-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000008006Member2016-02-012025-04-300000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000008006Member2016-02-012025-07-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000008006Member2016-02-012025-10-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000008006Member2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000008006Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000008006Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000008006Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedEnergyIndex17327AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17327BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000008006Member2026-01-310000734383nacc2:C000008006Membernacc2:AsiaCTIMember2026-01-310000734383nacc2:C000008006Membernacc2:EuropeCTIMember2026-01-310000734383nacc2:C000008006Membernacc2:NorthAmericaCTIMember2026-01-310000734383nacc2:C000008006Membernacc2:SouthAmericaCTIMember2026-01-310000734383nacc2:C000008006Membernacc2:CountryOtherNetLineCTIMember2026-01-310000734383nacc2:C000008006Member2024-02-012025-01-310000734383nacc2:C000008007Member2025-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000008007Member2016-01-312016-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000008007Member2016-02-012016-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000008007Member2016-02-012016-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000008007Member2016-02-012016-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000008007Member2016-02-012017-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000008007Member2016-02-012017-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000008007Member2016-02-012017-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000008007Member2016-02-012017-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000008007Member2016-02-012018-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000008007Member2016-02-012018-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000008007Member2016-02-012018-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000008007Member2016-02-012018-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000008007Member2016-02-012019-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000008007Member2016-02-012019-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000008007Member2016-02-012019-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000008007Member2016-02-012019-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000008007Member2016-02-012020-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000008007Member2016-02-012020-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000008007Member2016-02-012020-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000008007Member2016-02-012020-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000008007Member2016-02-012021-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000008007Member2016-02-012021-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000008007Member2016-02-012021-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000008007Member2016-02-012021-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000008007Member2016-02-012022-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000008007Member2016-02-012022-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000008007Member2016-02-012022-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000008007Member2016-02-012022-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000008007Member2016-02-012023-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000008007Member2016-02-012023-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000008007Member2016-02-012023-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000008007Member2016-02-012023-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000008007Member2016-02-012024-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000008007Member2016-02-012024-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000008007Member2016-02-012024-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000008007Member2016-02-012024-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000008007Member2016-02-012025-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000008007Member2016-02-012025-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000008007Member2016-02-012025-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000008007Member2016-02-012025-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000008007Member2016-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000008007Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000008007Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000008007Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17481AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17481BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000008007Member2026-01-310000734383nacc2:C000008007Membernacc2:AsiaCTIMember2026-01-310000734383nacc2:C000008007Membernacc2:EuropeCTIMember2026-01-310000734383nacc2:C000008007Membernacc2:NorthAmericaCTIMember2026-01-310000734383nacc2:C000008007Membernacc2:CountryOtherNetLineCTIMember2026-01-310000734383nacc2:C000008007Member2024-02-012025-01-310000734383nacc2:C000008008Member2025-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000008008Member2016-01-312016-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000008008Member2016-02-012016-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000008008Member2016-02-012016-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000008008Member2016-02-012016-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000008008Member2016-02-012017-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000008008Member2016-02-012017-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000008008Member2016-02-012017-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000008008Member2016-02-012017-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000008008Member2016-02-012018-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000008008Member2016-02-012018-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000008008Member2016-02-012018-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000008008Member2016-02-012018-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000008008Member2016-02-012019-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000008008Member2016-02-012019-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000008008Member2016-02-012019-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000008008Member2016-02-012019-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000008008Member2016-02-012020-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000008008Member2016-02-012020-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000008008Member2016-02-012020-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000008008Member2016-02-012020-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000008008Member2016-02-012021-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000008008Member2016-02-012021-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000008008Member2016-02-012021-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000008008Member2016-02-012021-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000008008Member2016-02-012022-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000008008Member2016-02-012022-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000008008Member2016-02-012022-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000008008Member2016-02-012022-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000008008Member2016-02-012023-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000008008Member2016-02-012023-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000008008Member2016-02-012023-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000008008Member2016-02-012023-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000008008Member2016-02-012024-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000008008Member2016-02-012024-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000008008Member2016-02-012024-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000008008Member2016-02-012024-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000008008Member2016-02-012025-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000008008Member2016-02-012025-04-300000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000008008Member2016-02-012025-07-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000008008Member2016-02-012025-10-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000008008Member2016-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000008008Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000008008Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000008008Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexMSCIAllCountryWorldIndexHealthCareIndex17341AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17341BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000008008Member2026-01-310000734383nacc2:C000008008Membernacc2:AsiaCTIMember2026-01-310000734383nacc2:C000008008Membernacc2:EuropeCTIMember2026-01-310000734383nacc2:C000008008Membernacc2:NorthAmericaCTIMember2026-01-310000734383nacc2:C000008008Membernacc2:CountryOtherNetLineCTIMember2026-01-310000734383nacc2:C000008008Member2024-02-012025-01-310000734383nacc2:C000031350Member2025-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000031350Member2016-01-312016-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000031350Member2016-02-012016-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000031350Member2016-02-012016-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000031350Member2016-02-012016-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000031350Member2016-02-012017-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000031350Member2016-02-012017-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000031350Member2016-02-012017-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000031350Member2016-02-012017-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000031350Member2016-02-012018-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000031350Member2016-02-012018-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000031350Member2016-02-012018-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000031350Member2016-02-012018-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000031350Member2016-02-012019-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000031350Member2016-02-012019-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000031350Member2016-02-012019-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000031350Member2016-02-012019-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000031350Member2016-02-012020-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000031350Member2016-02-012020-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000031350Member2016-02-012020-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000031350Member2016-02-012020-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000031350Member2016-02-012021-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000031350Member2016-02-012021-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000031350Member2016-02-012021-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000031350Member2016-02-012021-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000031350Member2016-02-012022-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000031350Member2016-02-012022-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000031350Member2016-02-012022-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000031350Member2016-02-012022-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000031350Member2016-02-012023-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000031350Member2016-02-012023-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000031350Member2016-02-012023-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000031350Member2016-02-012023-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000031350Member2016-02-012024-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000031350Member2016-02-012024-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000031350Member2016-02-012024-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000031350Member2016-02-012024-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000031350Member2016-02-012025-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000031350Member2016-02-012025-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000031350Member2016-02-012025-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000031350Member2016-02-012025-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000031350Member2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000031350Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000031350Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000031350Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:C000031350Member2021-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17385AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17385BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000031350Member2026-01-310000734383nacc2:C000031350Membernacc2:SectorCommunicationServicesSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorConsumerDiscretionarySectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorConsumerStaplesSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorEnergySectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorFinancialsSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorHealthCareSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorIndustrialsSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorInformationTechnologySectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorMaterialsSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorUtilitiesSectorMember2026-01-310000734383nacc2:C000031350Membernacc2:SectorOtherNetLineSectorMember2026-01-310000734383nacc2:C000031350Member2024-02-012025-01-310000734383nacc2:C000135474Member2025-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2025-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2025-02-012026-01-310000734383nacc2:C000135474Member2016-01-312016-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-01-312016-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-01-312016-01-310000734383nacc2:C000135474Member2016-02-012016-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012016-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012016-04-300000734383nacc2:C000135474Member2016-02-012016-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012016-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012016-07-310000734383nacc2:C000135474Member2016-02-012016-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012016-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012016-10-310000734383nacc2:C000135474Member2016-02-012017-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012017-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012017-01-310000734383nacc2:C000135474Member2016-02-012017-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012017-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012017-04-300000734383nacc2:C000135474Member2016-02-012017-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012017-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012017-07-310000734383nacc2:C000135474Member2016-02-012017-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012017-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012017-10-310000734383nacc2:C000135474Member2016-02-012018-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012018-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012018-01-310000734383nacc2:C000135474Member2016-02-012018-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012018-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012018-04-300000734383nacc2:C000135474Member2016-02-012018-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012018-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012018-07-310000734383nacc2:C000135474Member2016-02-012018-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012018-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012018-10-310000734383nacc2:C000135474Member2016-02-012019-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012019-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012019-01-310000734383nacc2:C000135474Member2016-02-012019-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012019-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012019-04-300000734383nacc2:C000135474Member2016-02-012019-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012019-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012019-07-310000734383nacc2:C000135474Member2016-02-012019-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012019-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012019-10-310000734383nacc2:C000135474Member2016-02-012020-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012020-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012020-01-310000734383nacc2:C000135474Member2016-02-012020-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012020-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012020-04-300000734383nacc2:C000135474Member2016-02-012020-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012020-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012020-07-310000734383nacc2:C000135474Member2016-02-012020-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012020-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012020-10-310000734383nacc2:C000135474Member2016-02-012021-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012021-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012021-01-310000734383nacc2:C000135474Member2016-02-012021-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012021-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012021-04-300000734383nacc2:C000135474Member2016-02-012021-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012021-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012021-07-310000734383nacc2:C000135474Member2016-02-012021-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012021-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012021-10-310000734383nacc2:C000135474Member2016-02-012022-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012022-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012022-01-310000734383nacc2:C000135474Member2016-02-012022-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012022-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012022-04-300000734383nacc2:C000135474Member2016-02-012022-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012022-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012022-07-310000734383nacc2:C000135474Member2016-02-012022-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012022-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012022-10-310000734383nacc2:C000135474Member2016-02-012023-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012023-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012023-01-310000734383nacc2:C000135474Member2016-02-012023-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012023-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012023-04-300000734383nacc2:C000135474Member2016-02-012023-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012023-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012023-07-310000734383nacc2:C000135474Member2016-02-012023-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012023-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012023-10-310000734383nacc2:C000135474Member2016-02-012024-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012024-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012024-01-310000734383nacc2:C000135474Member2016-02-012024-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012024-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012024-04-300000734383nacc2:C000135474Member2016-02-012024-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012024-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012024-07-310000734383nacc2:C000135474Member2016-02-012024-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012024-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012024-10-310000734383nacc2:C000135474Member2016-02-012025-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012025-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012025-01-310000734383nacc2:C000135474Member2016-02-012025-04-300000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012025-04-300000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012025-04-300000734383nacc2:C000135474Member2016-02-012025-07-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012025-07-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012025-07-310000734383nacc2:C000135474Member2016-02-012025-10-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012025-10-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012025-10-310000734383nacc2:C000135474Member2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2016-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2016-02-012026-01-310000734383nacc2:C000135474Memberoef:WithoutSalesLoadMember2025-02-012026-01-310000734383nacc2:C000135474Memberoef:WithoutSalesLoadMember2021-02-012026-01-310000734383nacc2:C000135474Memberoef:WithoutSalesLoadMember2016-02-012026-01-310000734383nacc2:NACC2IndexSplicedSPUSDividendGrowersIndexTR17324AdditionalIndexMember2021-02-012026-01-310000734383nacc2:NACC2IndexDowJonesUSTotalStockMarketFloatAdjustedIndex17324BroadBasedIndexMember2021-02-012026-01-310000734383nacc2:C000135474Member2026-01-310000734383nacc2:C000135474Membernacc2:SectorCommunicationServicesSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorConsumerDiscretionarySectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorConsumerStaplesSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorEnergySectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorFinancialsSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorHealthCareSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorIndustrialsSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorInformationTechnologySectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorMaterialsSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorUtilitiesSectorMember2026-01-310000734383nacc2:C000135474Membernacc2:SectorOtherNetLineSectorMember2026-01-310000734383nacc2:C000135474Member2024-02-012025-01-31iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureutr:Dnacc2:Holding
Image

Vanguard Dividend Growth Fund

Investor Shares (VDIGX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Dividend Growth Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$21
0.20%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund underperformed its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • Eight of 11 industry sectors detracted from relative performance. Information technology hurt results the most due to weak stock selection, while health care and financials also weighed heavily. Strong selection in communication services added value, but the sector’s modest weighting muted its impact on the Fund’s overall performance.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $10,000

Line graph showing cumulative performance of $10,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Investor Shares  $29,708 
Dividend Growth Spliced Index $35,926 
Dow Jones U.S. Total Stock Market Float Adjusted Index $40,665.
Table Summary
Investor Shares
Dividend Growth Spliced Index
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$10,000
$10,000
$10,000
2016
$10,644
$10,722
$10,765
2016
$11,065
$11,335
$11,417
2016
$10,615
$11,005
$11,215
2017
$11,206
$11,667
$12,172
2017
$11,861
$12,376
$12,764
2017
$12,328
$12,702
$13,258
2017
$12,553
$13,227
$13,901
2018
$13,856
$14,723
$15,235
2018
$13,241
$13,816
$14,431
2018
$14,018
$14,765
$15,436
2018
$13,805
$14,454
$14,813
2019
$14,082
$14,600
$14,881
2019
$15,546
$16,030
$16,247
2019
$16,307
$16,662
$16,502
2019
$16,476
$17,008
$16,797
2020
$17,368
$17,918
$17,913
2020
$15,604
$16,317
$16,055
2020
$16,937
$17,776
$18,284
2020
$17,126
$18,238
$18,475
2021
$18,589
$19,995
$21,593
2021
$21,238
$22,384
$24,245
2021
$22,348
$23,479
$25,402
2021
$23,082
$24,267
$26,617
2022
$23,359
$24,149
$25,587
2022
$22,873
$22,956
$23,429
2022
$22,743
$22,959
$23,425
2022
$22,405
$22,381
$22,107
2023
$23,181
$23,681
$23,433
2023
$23,571
$24,001
$23,728
2023
$24,080
$25,447
$26,381
2023
$22,582
$23,554
$23,963
2024
$25,294
$26,694
$27,919
2024
$25,463
$27,204
$29,048
2024
$26,973
$29,648
$31,949
2024
$27,450
$30,515
$33,068
2025
$27,873
$31,871
$35,256
2025
$26,716
$30,261
$32,317
2025
$27,793
$32,750
$36,974
2025
$28,723
$34,654
$39,980
2026
$29,708
$35,926
$40,665

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Investor Shares
6.58%
9.83%
11.50%
Dividend Growth Spliced Index
12.72%
12.43%
13.64%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$40,339
Number of Portfolio Holdings
55
Portfolio Turnover Rate
40%
Total Investment Advisory Fees (in thousands)
$26,394

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Communication Services
3.6%
Consumer Discretionary
11.4%
Consumer Staples
8.2%
Financials
17.6%
Health Care
16.8%
Industrials
14.5%
Information Technology
23.3%
Materials
2.7%
Other Assets and Liabilities—Net
1.9%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

How has the Fund changed?

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities through its wholly-owned subsidiaries, Vanguard Capital Management, LLC and Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR57 

Image

Vanguard Energy Fund

Investor Shares (VGENX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Energy Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$51
0.45%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund outperformed its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • The Fund’s stock selection in multi-utilities contributed the most to relative performance. An overweight allocation to semiconductors and an underweight to independent power producers & energy traders also added to results. On the other hand, oil & gas exploration & production detracted the most.

  • Regionally, Europe boosted relative performance, while North America and emerging markets detracted.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $10,000

Line graph showing cumulative performance of $10,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Investor Shares  $22,408 
Spliced Energy Index $17,804 
Dow Jones U.S. Total Stock Market Float Adjusted Index $40,665.
Table Summary
Investor Shares
Spliced Energy Index
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$10,000
$10,000
$10,000
2016
$12,053
$11,847
$10,765
2016
$12,177
$11,807
$11,417
2016
$12,439
$12,114
$11,215
2017
$13,273
$12,854
$12,172
2017
$12,622
$12,403
$12,764
2017
$12,569
$12,485
$13,258
2017
$13,222
$13,276
$13,901
2018
$14,434
$14,619
$15,235
2018
$14,754
$14,631
$14,431
2018
$15,131
$15,214
$15,436
2018
$13,434
$13,830
$14,813
2019
$12,777
$13,448
$14,881
2019
$13,490
$13,944
$16,247
2019
$12,684
$13,381
$16,502
2019
$12,219
$12,963
$16,797
2020
$11,940
$12,509
$17,913
2020
$8,641
$8,923
$16,055
2020
$8,879
$8,902
$18,284
2020
$7,547
$7,525
$18,475
2021
$9,128
$8,976
$21,593
2021
$10,196
$9,914
$24,245
2021
$10,341
$10,024
$25,402
2021
$11,482
$10,971
$26,617
2022
$12,445
$11,676
$25,587
2022
$12,892
$12,132
$23,429
2022
$13,335
$12,314
$23,425
2022
$13,841
$12,507
$22,107
2023
$14,525
$13,063
$23,433
2023
$14,639
$13,001
$23,728
2023
$15,159
$13,209
$26,381
2023
$15,034
$12,669
$23,963
2024
$15,107
$13,078
$27,919
2024
$16,782
$14,216
$29,048
2024
$17,482
$14,664
$31,949
2024
$17,569
$14,566
$33,068
2025
$17,561
$14,294
$35,256
2025
$18,039
$14,402
$32,317
2025
$19,275
$15,537
$36,974
2025
$20,385
$16,265
$39,980
2026
$22,408
$17,804
$40,665

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Investor Shares
27.60%
19.67%
8.40%
Spliced Energy Index
24.55%
14.68%
5.94%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$6,631
Number of Portfolio Holdings
43
Portfolio Turnover Rate
19%
Total Investment Advisory Fees (in thousands)
$11,886

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Asia
3.2%
Europe
32.8%
North America
61.9%
South America
1.0%
Other Assets and Liabilities—Net
1.1%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

How has the Fund changed?

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities through its wholly-owned subsidiaries, Vanguard Capital Management, LLC and Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR51 

Image

Vanguard Energy Fund

Admiral™ Shares (VGELX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Energy Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$42
0.37%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund outperformed its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • The Fund’s stock selection in multi-utilities contributed the most to relative performance. An overweight allocation to semiconductors and an underweight to independent power producers & energy traders also added to results. On the other hand, oil & gas exploration & production detracted the most.

  • Regionally, Europe boosted relative performance, while North America and emerging markets detracted.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $50,000

Line graph showing cumulative performance of $50,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Admiral Shares $112,936 
Spliced Energy Index $89,019 
Dow Jones U.S. Total Stock Market Float Adjusted Index $203,323.
Table Summary
Admiral Shares
Spliced Energy Index
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$50,000
$50,000
$50,000
2016
$60,277
$59,233
$53,827
2016
$60,903
$59,034
$57,084
2016
$62,235
$60,571
$56,073
2017
$66,417
$64,271
$60,862
2017
$63,168
$62,014
$63,818
2017
$62,920
$62,427
$66,290
2017
$66,199
$66,380
$69,507
2018
$72,286
$73,095
$76,175
2018
$73,907
$73,155
$72,156
2018
$75,808
$76,069
$77,182
2018
$67,322
$69,152
$74,067
2019
$64,047
$67,241
$74,404
2019
$67,631
$69,721
$81,235
2019
$63,600
$66,906
$82,511
2019
$61,288
$64,816
$83,987
2020
$59,883
$62,547
$89,564
2020
$43,352
$44,614
$80,274
2020
$44,549
$44,512
$91,422
2020
$37,875
$37,626
$92,375
2021
$45,825
$44,881
$107,965
2021
$51,195
$49,568
$121,223
2021
$51,929
$50,122
$127,008
2021
$57,682
$54,857
$133,086
2022
$62,519
$58,381
$127,935
2022
$64,778
$60,660
$117,147
2022
$67,030
$61,570
$117,125
2022
$69,580
$62,535
$110,536
2023
$73,039
$65,316
$117,165
2023
$73,612
$65,005
$118,641
2023
$76,242
$66,047
$131,906
2023
$75,629
$63,345
$119,815
2024
$76,024
$65,390
$139,596
2024
$84,468
$71,081
$145,242
2024
$88,022
$73,318
$159,745
2024
$88,468
$72,828
$165,337
2025
$88,438
$71,471
$176,278
2025
$90,858
$72,010
$161,587
2025
$97,114
$77,687
$184,871
2025
$102,717
$81,323
$199,899
2026
$112,936
$89,019
$203,323

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Admiral Shares
27.70%
19.77%
8.49%
Spliced Energy Index
24.55%
14.68%
5.94%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$6,631
Number of Portfolio Holdings
43
Portfolio Turnover Rate
19%
Total Investment Advisory Fees (in thousands)
$11,886

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Asia
3.2%
Europe
32.8%
North America
61.9%
South America
1.0%
Other Assets and Liabilities—Net
1.1%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

How has the Fund changed?

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities through its wholly-owned subsidiaries, Vanguard Capital Management, LLC and Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR551 

Image

Vanguard Health Care Fund

Investor Shares (VGHCX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$35
0.33%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund outperformed its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • Eight of the Fund’s 10 subsectors outperformed those of its benchmark. Health care equipment and biotechnology contributed the most to relative performance because of differences in allocation weights and stock selection. Stock selection in pharmaceuticals was also a top contributor.

  • The largest detractors were stock selection in health care facilities and an overweight allocation to the poorly performing managed health care subsector.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $10,000

Line graph showing cumulative performance of $10,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Investor Shares  $23,055 
MSCI All Country World Index Health Care Index $23,308 
Dow Jones U.S. Total Stock Market Float Adjusted Index $40,665.
Table Summary
Investor Shares
MSCI All Country World Index Health Care Index
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$10,000
$10,000
$10,000
2016
$10,275
$10,448
$10,765
2016
$11,100
$11,160
$11,417
2016
$9,814
$9,964
$11,215
2017
$10,271
$10,327
$12,172
2017
$11,188
$11,153
$12,764
2017
$11,848
$11,711
$13,258
2017
$11,688
$11,855
$13,901
2018
$12,560
$12,832
$15,235
2018
$11,698
$12,117
$14,431
2018
$12,837
$13,029
$15,436
2018
$12,557
$12,736
$14,813
2019
$12,906
$12,983
$14,881
2019
$12,559
$13,010
$16,247
2019
$12,949
$13,354
$16,502
2019
$13,585
$14,009
$16,797
2020
$14,604
$14,931
$17,913
2020
$14,737
$14,982
$16,055
2020
$15,939
$16,136
$18,284
2020
$15,228
$15,443
$18,475
2021
$16,964
$17,580
$21,593
2021
$17,266
$18,172
$24,245
2021
$18,605
$19,678
$25,402
2021
$18,769
$19,855
$26,617
2022
$17,724
$18,891
$25,587
2022
$17,698
$18,733
$23,429
2022
$18,181
$18,824
$23,425
2022
$18,230
$18,345
$22,107
2023
$18,889
$19,104
$23,433
2023
$19,592
$19,517
$23,728
2023
$19,611
$19,566
$26,381
2023
$17,927
$18,023
$23,963
2024
$20,102
$20,334
$27,919
2024
$20,362
$20,449
$29,048
2024
$22,230
$22,078
$31,949
2024
$21,175
$21,562
$33,068
2025
$20,697
$21,322
$35,256
2025
$19,700
$20,718
$32,317
2025
$18,570
$19,800
$36,974
2025
$21,286
$21,574
$39,980
2026
$23,055
$23,308
$40,665

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Investor Shares
11.39%
6.33%
8.71%
MSCI All Country World Index Health Care Index
9.31%
5.80%
8.83%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$39,264
Number of Portfolio Holdings
101
Portfolio Turnover Rate
47%
Total Investment Advisory Fees (in thousands)
$52,431

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Asia
6.0%
Europe
20.0%
North America
71.5%
Other Assets and Liabilities—Net
2.5%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

How has the Fund changed?

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities through its wholly-owned subsidiaries, Vanguard Capital Management, LLC and Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR52 

Image

Vanguard Health Care Fund

Admiral™ Shares (VGHAX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$29
0.27%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund outperformed its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • Eight of the Fund’s 10 subsectors outperformed those of its benchmark. Health care equipment and biotechnology contributed the most to relative performance because of differences in allocation weights and stock selection. Stock selection in pharmaceuticals was also a top contributor.

  • The largest detractors were stock selection in health care facilities and an overweight allocation to the poorly performing managed health care subsector.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $50,000

Line graph showing cumulative performance of $50,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Admiral Shares $115,867 
MSCI All Country World Index Health Care Index $116,541 
Dow Jones U.S. Total Stock Market Float Adjusted Index $203,323.
Table Summary
Admiral Shares
MSCI All Country World Index Health Care Index
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$50,000
$50,000
$50,000
2016
$51,383
$52,240
$53,827
2016
$55,513
$55,798
$57,084
2016
$49,088
$49,819
$56,073
2017
$51,382
$51,634
$60,862
2017
$55,976
$55,765
$63,818
2017
$59,287
$58,557
$66,290
2017
$58,489
$59,275
$69,507
2018
$62,864
$64,158
$76,175
2018
$58,557
$60,585
$72,156
2018
$64,270
$65,144
$77,182
2018
$62,876
$63,679
$74,067
2019
$64,628
$64,915
$74,404
2019
$62,894
$65,049
$81,235
2019
$64,856
$66,769
$82,511
2019
$68,054
$70,045
$83,987
2020
$73,169
$74,657
$89,564
2020
$73,846
$74,911
$80,274
2020
$79,875
$80,682
$91,422
2020
$76,324
$77,217
$92,375
2021
$85,030
$87,901
$107,965
2021
$86,560
$90,861
$121,223
2021
$93,278
$98,391
$127,008
2021
$94,112
$99,276
$133,086
2022
$88,883
$94,455
$127,935
2022
$88,772
$93,666
$117,147
2022
$91,200
$94,120
$117,125
2022
$91,459
$91,723
$110,536
2023
$94,775
$95,522
$117,165
2023
$98,318
$97,583
$118,641
2023
$98,427
$97,832
$131,906
2023
$89,980
$90,116
$119,815
2024
$100,920
$101,669
$139,596
2024
$102,235
$102,247
$145,242
2024
$111,623
$110,388
$159,745
2024
$106,339
$107,809
$165,337
2025
$103,955
$106,612
$176,278
2025
$98,961
$103,589
$161,587
2025
$93,297
$99,001
$184,871
2025
$106,965
$107,869
$199,899
2026
$115,867
$116,541
$203,323

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Admiral Shares
11.46%
6.38%
8.77%
MSCI All Country World Index Health Care Index
9.31%
5.80%
8.83%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$39,264
Number of Portfolio Holdings
101
Portfolio Turnover Rate
47%
Total Investment Advisory Fees (in thousands)
$52,431

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Asia
6.0%
Europe
20.0%
North America
71.5%
Other Assets and Liabilities—Net
2.5%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

How has the Fund changed?

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities through its wholly-owned subsidiaries, Vanguard Capital Management, LLC and Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR552 

Image

Vanguard Dividend Appreciation Index Fund

ETF Shares (VIGNYSE Arca

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
ETF Shares
$5
0.05%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund performed in line with its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • Eight of 10 industry sectors contributed positively to the benchmark’s return, reflecting broad-based strength. Information technology and financials contributed the most, while industrials, health care, energy, and consumer staples also added meaningful support. Consumer discretionary and communication services modestly detracted.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $10,000

Line graph showing cumulative performance of $10,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
ETF Shares Net Asset Value  $35,690 
Spliced S&P U.S. Dividend Growers Index TR $35,926 
Dow Jones U.S. Total Stock Market Float Adjusted Index $40,665.
Table Summary
ETF Shares Net Asset Value
Spliced S&P U.S. Dividend Growers Index TR
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$10,000
$10,000
$10,000
2016
$10,718
$10,722
$10,765
2016
$11,328
$11,335
$11,417
2016
$10,998
$11,005
$11,215
2017
$11,659
$11,667
$12,172
2017
$12,366
$12,376
$12,764
2017
$12,690
$12,702
$13,258
2017
$13,212
$13,227
$13,901
2018
$14,702
$14,723
$15,235
2018
$13,795
$13,816
$14,431
2018
$14,742
$14,765
$15,436
2018
$14,429
$14,454
$14,813
2019
$14,574
$14,600
$14,881
2019
$16,001
$16,030
$16,247
2019
$16,630
$16,662
$16,502
2019
$16,973
$17,008
$16,797
2020
$17,880
$17,918
$17,913
2020
$16,279
$16,317
$16,055
2020
$17,717
$17,776
$18,284
2020
$18,175
$18,238
$18,475
2021
$19,924
$19,995
$21,593
2021
$22,301
$22,384
$24,245
2021
$23,388
$23,479
$25,402
2021
$24,173
$24,267
$26,617
2022
$24,050
$24,149
$25,587
2022
$22,858
$22,956
$23,429
2022
$22,856
$22,959
$23,425
2022
$22,274
$22,381
$22,107
2023
$23,563
$23,681
$23,433
2023
$23,877
$24,001
$23,728
2023
$25,314
$25,447
$26,381
2023
$23,428
$23,554
$23,963
2024
$26,546
$26,694
$27,919
2024
$27,051
$27,204
$29,048
2024
$29,478
$29,648
$31,949
2024
$30,335
$30,515
$33,068
2025
$31,679
$31,871
$35,256
2025
$30,072
$30,261
$32,317
2025
$32,544
$32,750
$36,974
2025
$34,432
$34,654
$39,980
2026
$35,690
$35,926
$40,665

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
ETF Shares Net Asset Value
12.66%
12.37%
13.57%
ETF Shares Market Price
12.69%
12.38%
13.57%
Spliced S&P U.S. Dividend Growers Index TR
12.72%
12.43%
13.64%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$121,514
Number of Portfolio Holdings
347
Portfolio Turnover Rate
8%
Total Investment Advisory Fees (in thousands)
$2,256

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Communication Services
0.5%
Consumer Discretionary
5.0%
Consumer Staples
10.0%
Energy
3.1%
Financials
21.1%
Health Care
16.3%
Industrials
11.6%
Information Technology
25.9%
Materials
3.2%
Utilities
2.7%
Other Assets and Liabilities—Net
0.6%

This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.

How has the Fund changed?

The Fund's principal investment strategy disclosure was modified to add that the Fund may become nondiversified, as defined under the Investment Company Act of 1940, solely as a result of an index rebalance or market movement. The Fund added nondiversification risk and index concentration risk as principal risks.

 

During the reporting period, the expense ratio for the ETF Share class was reduced. Subsequent to the Fund's fiscal year end, the expense ratio for the ETF Share class was further reduced. 

 

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities for the fund through its wholly-owned subsidiary, Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR920 

Image

Vanguard Dividend Appreciation Index Fund

Admiral™ Shares (VDADX

Annual Shareholder Report | January 31, 2026

This annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2025, to January 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447. The report describes changes to the Fund that occurred during the reporting period.

What were the Fund costs for the last year?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$7
0.07%

How did the Fund perform during the reporting period? 

  • For the 12 months ended January 31, 2026, the Fund performed in line with its benchmark.

  • The first part of the period was marked by volatility in the financial markets amid fears that U.S. tariff announcements might spark trade wars and drag down global growth. Despite these concerns, markets posted solid gains for the 12 months, buoyed by optimism surrounding artificial intelligence, robust corporate earnings, and a more dovish monetary policy. The European Central Bank and the Federal Reserve each cut interest rates three times, while the Bank of England lowered rates four times.

  • Eight of 10 industry sectors contributed positively to the benchmark’s return, reflecting broad-based strength. Information technology and financials contributed the most, while industrials, health care, energy, and consumer staples also added meaningful support. Consumer discretionary and communication services modestly detracted.

How did the Fund perform over the past 10 years?

Keep in mind that the Fund's past performance does not indicate how the Fund will perform in the future. Updated performance information is available on our website at vanguard.com/performance or by calling Vanguard toll-free at 800-662-7447. The graph and returns shown do not reflect taxes that a shareholder would pay on fund distributions or on the sale of fund shares. 

Cumulative Performance: January 31, 2016, Through January 31, 2026

Initial Investment of $10,000

Line graph showing cumulative performance of $10,000 investment from January 31, 2016 through January 31, 2026. By the end of the period, the respective class' and index(es)' ending values are 
Admiral Shares  $35,645 
Spliced S&P U.S. Dividend Growers Index TR $35,926 
Dow Jones U.S. Total Stock Market Float Adjusted Index $40,665.
Table Summary
Admiral Shares
Spliced S&P U.S. Dividend Growers Index TR
Dow Jones U.S. Total Stock Market Float Adjusted Index
2016
$10,000
$10,000
$10,000
2016
$10,718
$10,722
$10,765
2016
$11,326
$11,335
$11,417
2016
$10,994
$11,005
$11,215
2017
$11,658
$11,667
$12,172
2017
$12,366
$12,376
$12,764
2017
$12,689
$12,702
$13,258
2017
$13,210
$13,227
$13,901
2018
$14,702
$14,723
$15,235
2018
$13,796
$13,816
$14,431
2018
$14,742
$14,765
$15,436
2018
$14,428
$14,454
$14,813
2019
$14,571
$14,600
$14,881
2019
$15,995
$16,030
$16,247
2019
$16,623
$16,662
$16,502
2019
$16,966
$17,008
$16,797
2020
$17,872
$17,918
$17,913
2020
$16,273
$16,317
$16,055
2020
$17,711
$17,776
$18,284
2020
$18,165
$18,238
$18,475
2021
$19,915
$19,995
$21,593
2021
$22,290
$22,384
$24,245
2021
$23,376
$23,479
$25,402
2021
$24,156
$24,267
$26,617
2022
$24,033
$24,149
$25,587
2022
$22,840
$22,956
$23,429
2022
$22,838
$22,959
$23,425
2022
$22,259
$22,381
$22,107
2023
$23,547
$23,681
$23,433
2023
$23,860
$24,001
$23,728
2023
$25,292
$25,447
$26,381
2023
$23,411
$23,554
$23,963
2024
$26,523
$26,694
$27,919
2024
$27,027
$27,204
$29,048
2024
$29,451
$29,648
$31,949
2024
$30,303
$30,515
$33,068
2025
$31,647
$31,871
$35,256
2025
$30,042
$30,261
$32,317
2025
$32,507
$32,750
$36,974
2025
$34,389
$34,654
$39,980
2026
$35,645
$35,926
$40,665

Average Annual Total Returns

Table Summary
 
1 Year
5 Years
10 Years
Admiral Shares
12.63%
12.35%
13.55%
Spliced S&P U.S. Dividend Growers Index TR
12.72%
12.43%
13.64%
Dow Jones U.S. Total Stock Market Float Adjusted Index
15.34%
13.50%
15.06%

Fund Statistics (as of January 31, 2026)

Table Summary
Fund Net Assets (in millions)
$121,514
Number of Portfolio Holdings
347
Portfolio Turnover Rate
8%
Total Investment Advisory Fees (in thousands)
$2,256

Portfolio Composition % of Net Assets  (as of January 31, 2026)

Table Summary
Communication Services
0.5%
Consumer Discretionary
5.0%
Consumer Staples
10.0%
Energy
3.1%
Financials
21.1%
Health Care
16.3%
Industrials
11.6%
Information Technology
25.9%
Materials
3.2%
Utilities
2.7%
Other Assets and Liabilities—Net
0.6%

This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.

How has the Fund changed?

The Fund's principal investment strategy disclosure was modified to add that the Fund may become nondiversified, as defined under the Investment Company Act of 1940, solely as a result of an index rebalance or market movement. The Fund added nondiversification risk and index concentration risk as principal risks.

 

During the reporting period, the expense ratio for the Admiral Share class was reduced. 

 

Effective January 12, 2026, The Vanguard Group, Inc. exercises portfolio management responsibilities for the fund through its wholly-owned subsidiary, Vanguard Portfolio Management, LLC.

 

This is a summary of certain changes to the Fund since January 31, 2025. For more complete information, you may review the Fund’s next prospectus, which we expect to be available by May 31, 2026, at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature or upon request at 800-662-7447.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Image

Connect with Vanguard® • vanguard.com

 

 

Fund Information 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing

800-749-7273

 

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

 

AR5702 

 

Item 2: Code of Ethics.

 

The Registrant has adopted a code of ethics that applies to the Registrant’s principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. The Code of Ethics was amended during the reporting period covered by this report to make certain technical, non-material changes.

 

Item 3: Audit Committee Financial Expert.

 

All members of the Audit and Risk Committee have been determined by the Registrant’s Board of Trustees to be Audit Committee Financial Experts and to be independent: Sarah Bloom Raskin, Peter F. Volanakis, Tara Bunch, and Mark Loughridge.

 

Item 4: Principal Accountant Fees and Services.

 

Includes fees billed in connection with services to the Registrant only.

 

   Fiscal Year Ended
January 31, 2026
   Fiscal Year Ended
January 31, 2025
 
(a)     Audit Fees.  $232,000   $231,000 
(b)     Audit-Related Fees.   0    0 
(c)     Tax Fees.   0    0 
(d)     All Other Fees.   0    0 
           Total.  $232,000   $231,000 

 

(e)         (1) Pre-Approval Policies. The audit committee is responsible for pre-approving all audit and non-audit services provided by PwC to: (i) the Vanguard funds; and (ii) Vanguard, or any entity controlled by Vanguard that provides ongoing services to the Vanguard funds. All services provided to Vanguard entities by the independent auditor, whether or not they are subject to preapproval, must be disclosed to the audit committee. The audit committee chair may preapprove any permissible audit and non-audit services as long as any preapproval is brought to the attention of the full audit committee at the next scheduled meeting.

 

(2) No percentage of the principal accountant’s fees or services were approved pursuant to the waiver provision of paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

 

 

 

 

(f)           For the most recent fiscal year, over 50% of the hours worked under the principal accountant’s engagement were not performed by persons other than full-time, permanent employees of the principal accountant.

 

(g)          Aggregate Non-Audit Fees.

 

Includes fees billed for non-audit services provided to the Registrant, other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.

 

   Fiscal Year Ended
January 31, 2026
   Fiscal Year Ended
January 31, 2025
 
Non-audit fees to the Registrant only, listed as (b) through (d) above.  $0   $0 
           
Non-audit Fees to other registered investment companies in the Vanguard complex, The Vanguard Group, Inc., and Vanguard Marketing Corporation.          
       Audit-Related Fees.  $3,960,022   $3,664,500 
       Tax Fees.  $1,772,928   $1,898,992 
       All Other Fees.  $25,000   $25,000 
       Total.  $5,757,950   $5,588,492 

 

(h)          For the most recent fiscal year, the Audit and Risk Committee has determined that the provision of all non-audit services was consistent with maintaining the principal accountant’s independence.

 

Item 5: Audit Committee of Listed Registrants.

 

The Registrant is a listed issuer as defined in rule 10A-3 under the Securities Exchange Act of 1934 (“Exchange Act”). The Registrant has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. The Registrant’s audit committee members are: Sarah Bloom Raskin, Peter F. Volanakis, Tara Bunch, and Mark Loughridge.

 

Item 6: Investments.

 

Not applicable. The complete schedule of investments is included in the financial statements filed under Item 7 of this Form.

 

 

 

 

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

 

 

 

Financial Statements
For the year ended January 31, 2026
Vanguard Dividend Growth Fund

 

Contents
Financial Statements

1
Report of Independent Registered Public Accounting Firm

11
Tax information

12
   

 

Dividend Growth Fund
Financial Statements
Schedule of Investments
As of January 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov.
    Shares Market
Value

($000)
Common Stocks (98.1%)
Communication Services (3.6%)
  Alphabet Inc. Class A  2,914,798    985,202
  Meta Platforms Inc. Class A    658,777    472,013
              1,457,215
Consumer Discretionary (11.4%)
  Home Depot Inc.  3,030,322  1,135,128
  NIKE Inc. Class B 17,195,331  1,062,844
  McDonald's Corp.  2,981,416    939,146
  TJX Cos. Inc.  6,098,428    913,606
  Marriott International Inc. Class A  1,792,868    565,291
              4,616,015
Consumer Staples (8.2%)
  Procter & Gamble Co.  5,152,314    781,967
  Coca-Cola Co.  9,921,310    742,213
  PepsiCo Inc.  3,229,382    496,130
  Colgate-Palmolive Co.  5,107,109    461,121
  Kroger Co.  6,678,181    419,723
  Walmart Inc.  1,842,302    219,492
  Diageo plc  8,140,603    187,318
              3,307,964
Financials (17.6%)
  Mastercard Inc. Class A  2,680,578  1,444,269
  Visa Inc. Class A  3,864,367  1,243,669
  Chubb Ltd.  3,256,611  1,008,117
  American Express Co.  2,562,336    902,378
  S&P Global Inc.  1,669,413    881,099
  Wells Fargo & Co.  9,415,331    851,993
  Marsh & McLennan Cos. Inc.  4,175,515    785,790
              7,117,315
Health Care (16.8%)
  Eli Lilly & Co.  1,658,839  1,720,465
  Danaher Corp.  4,259,581    932,380
  Stryker Corp.  2,519,320    931,040
  Johnson & Johnson  3,465,453    787,524
  Merck & Co. Inc.  6,731,846    742,320
  Abbott Laboratories  5,295,066    578,751
  Elevance Health Inc.  1,671,797    578,007
  Zoetis Inc.  3,920,147    489,313
              6,759,800
Industrials (14.5%)
  Northrop Grumman Corp.  1,899,668  1,315,064
  Honeywell International Inc.  4,544,293  1,033,918
  Automatic Data Processing Inc.  3,301,552    814,889
  Caterpillar Inc.    975,212    641,065
  Canadian National Railway Co.  6,413,560    616,981
  Trane Technologies plc  1,366,564    574,749
  AMETEK Inc.  1,965,228    440,172
  Deere & Co.    810,782    428,093
              5,864,931
Information Technology (23.3%)
  Broadcom Inc.  6,053,242  2,005,439
  Microsoft Corp.  4,423,694  1,903,471
  Texas Instruments Inc.  6,320,771  1,362,442
  Apple Inc.  5,058,731  1,312,640
  QUALCOMM Inc.  5,300,089    803,441
  Accenture plc Class A  2,926,694    771,594
  Amphenol Corp. Class A  4,539,535    654,056
1

 

Dividend Growth Fund
    Shares Market
Value

($000)
  Intuit Inc.  1,163,434    580,460
              9,393,543
Materials (2.7%)
  Linde plc  2,345,109  1,071,645
Total Common Stocks (Cost $22,150,937) 39,588,428
Temporary Cash Investments (1.8%)
Money Market Fund (0.0%)
1 Vanguard Market Liquidity Fund, 3.704%         262         26
    Face
Amount
($000)
 
Repurchase Agreements (1.8%)
  Bank of America Securities, LLC 3.670%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $60,018, collateralized by U.S. Treasury Obligations 0.000%–4.500%, 4/7/2026–11/15/2051, with a value of $61,200)
    60,000     60,000
  Bank of America Securities, LLC 3.680%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $150,046, collateralized by U.S. Government Agency Obligations 3.500%, 12/1/2055, with a value of $153,000)
   150,000    150,000
  Credit Agricole Securities 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $11,403, collateralized by U.S. Treasury Obligations 4.125%, 2/29/2032, with a value of $11,628)
    11,400     11,400
  JP Morgan Securities, LLC 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $100,031, collateralized by U.S. Treasury Obligations 0.000%, 2/19/2026, with a value of $102,000)
   100,000    100,000
  Natixis SA 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $131,540, collateralized by U.S. Treasury and Government Agency Obligations 0.125%–4.000%, 7/31/2026–11/15/2046, with a value of $134,130)
   131,500    131,500
  NatWest Markets plc 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $18,906, collateralized by U.S. Treasury Obligations 3.375%, 9/15/2028, with a value of $19,278)
    18,900     18,900
  Nomura International plc 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $165,050, collateralized by U.S. Treasury Obligations 0.000%–4.375%, 3/31/2026–8/15/2034, with a value of $168,300)
   165,000    165,000
  Societe Generale 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $66,320, collateralized by U.S. Treasury Obligations 1.875%, 2/15/2051, with a value of $67,626)
    66,300     66,300
                703,100
Total Temporary Cash Investments (Cost $703,126) 703,126
Total Investments (99.9%) (Cost $22,854,063) 40,291,554
Other Assets and Liabilities—Net (0.1%) 47,774
Net Assets (100%) 40,339,328
Cost is in $000.
See Note A in Notes to Financial Statements.
1 Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
  
See accompanying Notes, which are an integral part of the Financial Statements.
2

 

Dividend Growth Fund
Statement of Assets and Liabilities
As of January 31, 2026
($000s, except shares and per-share amounts) Amount
Assets  
Investments in Securities, at Value  
Unaffiliated Issuers (Cost $22,854,037) 40,291,528
Affiliated Issuers (Cost $26) 26
Total Investments in Securities 40,291,554
Investment in Vanguard 968
Cash 31
Foreign Currency, at Value (Cost $6) 6
Receivables for Investment Securities Sold 80,990
Receivables for Accrued Income 42,294
Receivables for Capital Shares Issued 4,564
Total Assets 40,420,407
Liabilities  
Payables for Investment Securities Purchased 37,254
Payables to Investment Advisor 5,639
Payables for Capital Shares Redeemed 35,694
Payables to Vanguard 2,492
Total Liabilities 81,079
Net Assets 40,339,328
At January 31, 2026, net assets consisted of:  
   
Paid-in Capital 20,450,391
Total Distributable Earnings (Loss) 19,888,937
Net Assets 40,339,328
 
Net Assets  
Applicable to 1,216,462,258 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
40,339,328
Net Asset Value Per Share $33.16
  
See accompanying Notes, which are an integral part of the Financial Statements.
3

 

Dividend Growth Fund
Statement of Operations
  Year Ended
January 31, 2026
  ($000)
Investment Income  
Income  
Dividends1 737,407
Interest 38,911
Securities Lending—Net 2
Total Income 776,320
Expenses  
Investment Advisory Fees—Note B  
Basic Fee 59,700
Performance Adjustment (33,306)
The Vanguard Group—Note C  
Management and Administrative 61,263
Marketing and Distribution 1,984
Custodian Fees 231
Auditing Fees 31
Shareholders’ Reports and Proxy Fees 424
Trustees’ Fees and Expenses 27
Other Expenses 23
Total Expenses 90,377
Expenses Paid Indirectly (33)
Net Expenses 90,344
Net Investment Income 685,976
Realized Net Gain (Loss)  
Investment Securities Sold2 8,741,587
Foreign Currencies 715
Realized Net Gain (Loss) 8,742,302
Change in Unrealized Appreciation (Depreciation)  
Investment Securities2 (6,632,158)
Foreign Currencies 130
Change in Unrealized Appreciation (Depreciation) (6,632,028)
Net Increase (Decrease) in Net Assets Resulting from Operations 2,796,250
1 Dividends are net of foreign withholding taxes of $5,288.
2 Change in unrealized appreciation (depreciation) from an affiliated company of the fund was less than $1. There was no realized net gain (loss) during the period. Purchases and sales are for temporary cash investment purposes.
  
See accompanying Notes, which are an integral part of the Financial Statements.
4

 

Dividend Growth Fund
Statement of Changes in Net Assets
  Year Ended January 31,
  2026
($000)
2025
($000)
Increase (Decrease) in Net Assets    
Operations    
Net Investment Income 685,976 884,219
Realized Net Gain (Loss) 8,742,302 5,624,161
Change in Unrealized Appreciation (Depreciation) (6,632,028) (1,403,256)
Net Increase (Decrease) in Net Assets Resulting from Operations 2,796,250 5,105,124
Distributions    
Total Distributions (7,277,528) (5,600,894)
Capital Share Transactions    
Issued 2,455,621 2,676,285
Issued in Lieu of Cash Distributions 6,339,899 4,931,591
Redeemed (14,399,407) (9,240,368)
Net Increase (Decrease) from Capital Share Transactions (5,603,887) (1,632,492)
Total Increase (Decrease) (10,085,165) (2,128,262)
Net Assets    
Beginning of Period 50,424,493 52,552,755
End of Period 40,339,328 50,424,493
  
See accompanying Notes, which are an integral part of the Financial Statements.
5

 

Dividend Growth Fund
Financial Highlights
For a Share Outstanding
Throughout Each Period
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $37.14 $37.76 $35.42 $37.85 $31.82
Investment Operations          
Net Investment Income1 .540 .658 .620 .596 .576
Net Realized and Unrealized Gain (Loss) on Investments 1.769 3.053 2.573 (.893) 7.593
Total from Investment Operations 2.309 3.711 3.193 (.297) 8.169
Distributions          
Dividends from Net Investment Income (.577) (.679) (.629) (.590) (.574)
Distributions from Realized Capital Gains (5.712) (3.652) (.224) (1.543) (1.565)
Total Distributions (6.289) (4.331) (.853) (2.133) (2.139)
Net Asset Value, End of Period $33.16 $37.14 $37.76 $35.42 $37.85
Total Return2 6.58% 10.20% 9.11% -0.76% 25.66%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $40,339 $50,424 $52,553 $53,452 $54,186
Ratio of Total Expenses to Average Net Assets3 0.20%4 0.22%5 0.29%5 0.30%5 0.27%
Ratio of Net Investment Income to Average Net Assets 1.50% 1.68% 1.74% 1.68% 1.56%
Portfolio Turnover Rate 40% 16% 9% 11% 15%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 Includes performance-based investment advisory fee increases (decreases) of (0.07%), (0.05%), 0.02%, 0.03%, and (0.00%).
4 The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.20%.
5 The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.22%, 0.29%, and 0.30%, respectively.
  
See accompanying Notes, which are an integral part of the Financial Statements.
6

 

Dividend Growth Fund
Notes to Financial Statements
Vanguard Dividend Growth Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund.
A. The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund’s pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund’s pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund’s tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund’s tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund’s financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund’s regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund’s board of trustees and included in Management and Administrative expenses on the fund’s Statement of Operations. Any borrowings under either facility bear interest at an agreed-upon spread plus the higher of the federal funds effective rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate inclusive of an additional agreed-upon spread. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the “Order”) from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the “Interfund
7

 

Dividend Growth Fund
Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund’s investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day’s notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the year ended January 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Premiums and discounts on debt securities are amortized and accreted, respectively, to interest income over the lives of the respective securities, except for premiums on certain callable debt securities that are amortized to the earliest call date. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
B. Wellington Management Company LLP provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund’s performance relative to the S&P U.S. Dividend Growers Index for the preceding three years. For the year ended January 31, 2026, the investment advisory fee represented an effective annual basic rate of 0.13% of the fund’s average net assets, before a net decrease of $33,306,000 (0.07%) based on performance.
C. In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At January 31, 2026, the fund had contributed to Vanguard capital in the amount of $968,000, representing less than 0.01% of the fund’s net assets and 0.39% of Vanguard’s capital received pursuant to the FSA. The fund’s trustees and officers are also directors and employees, respectively, of Vanguard.
D. The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. For the year ended January 31, 2026, these arrangements reduced the fund’s expenses by $33,000 (an annual rate of less than 0.01% of average net assets).
E. Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.
Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund’s own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund’s investments as of January 31, 2026, based on the inputs used to value them:
  Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments        
Assets        
Common Stocks 39,401,110 187,318 39,588,428
Temporary Cash Investments 26 703,100 703,126
Total 39,401,136 890,418 40,291,554
F. Permanent differences between book-basis and tax-basis components of net assets are reclassified among capital accounts in the financial statements to reflect their tax character. These reclassifications have no effect on net assets or net asset value per share. Examples of permanent differences include, but are not limited to, the accounting for passive foreign investment companies, in-kind redemptions, swap agreements, and distributions in connection with fund share redemptions.
Permanent differences were reclassified between the following accounts: Amount
($000)
Paid-in Capital 858,767
Total Distributable Earnings (Loss) (858,767)
Temporary differences between book-basis and tax-basis components of total distributable earnings (loss) arise when certain items of income, gain, or loss are recognized in different periods for financial statement and tax purposes; these differences will reverse at some time in the future. Examples of temporary differences include, but are not limited to, capital loss carryforwards, the deferral of losses from wash sales, the recognition of unrealized
8

 

Dividend Growth Fund
gains or losses from certain derivative contracts, and the recognition of unrealized gains from passive foreign investment companies. As of period end, the tax-basis components of total distributable earnings (loss) are detailed in the table as follows:
  Amount
($000)
Undistributed Ordinary Income 304,045
Undistributed Long-Term Gains 2,187,360
Net Unrealized Gains (Losses) 17,397,532
Capital Loss Carryforwards
Qualified Late-Year Losses
Other Temporary Differences
Total 19,888,937
The tax character of distributions paid was as follows:
  Year Ended January 31,
  2026
Amount
($000)
2025
Amount
($000)
Ordinary Income* 1,082,337 937,092
Long-Term Capital Gains 6,195,191 4,663,802
Total 7,277,528 5,600,894
* Includes short-term capital gains, if any.
As of January 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows:
  Amount
($000)
Tax Cost 22,894,152
Gross Unrealized Appreciation 17,934,072
Gross Unrealized Depreciation (536,670)
Net Unrealized Appreciation (Depreciation) 17,397,402
G. During the year ended January 31, 2026, the fund purchased $17,810,981,000 of investment securities and sold $29,622,381,000 of investment securities, other than temporary cash investments.
The fund purchased securities from and sold securities to other funds or accounts managed by its investment advisor or their affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the year ended January 31, 2026, such purchases were $0 and sales were $186,585,000, resulting in net realized gain of $30,923,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
H. Capital shares issued and redeemed were:
    
  Year Ended January 31,
  2026
Shares
(000)
2025
Shares
(000)
Issued 69,573 68,514
Issued in Lieu of Cash Distributions 189,599 134,779
Redeemed (400,538) (237,393)
Net Increase (Decrease) in Shares Outstanding (141,366) (34,100)
I. Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance.
To the extent the fund’s investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
J. Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their operating results regularly reviewed by a chief operating decision maker (“CODM”). The fund is considered a single segment. Vanguard’s chief executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund’s chief financial officer collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund’s daily operations. Through these committees, the CODM manages the fund’s operations to achieve a single investment objective, as detailed in its
9

 

Dividend Growth Fund
prospectus, through the execution of the fund’s investment strategies. When assessing segment performance and making decisions about segment resources, the CODM relies on the fund’s portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the information contained in the fund’s financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying financial statements.
K. Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would require recognition or disclosure in these financial statements.
10

 

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Vanguard Specialized Funds and Shareholders of Vanguard Dividend Growth Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Vanguard Dividend Growth Fund (one of the funds constituting Vanguard Specialized Funds, referred to hereafter as the "Fund") as of January 31, 2026, the related statement of operations for the year ended January 31, 2026, the statement of changes in net assets for each of the two years in the period ended January 31, 2026, including the related notes, and the financial highlights for each of the five years in the period ended January 31, 2026 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of January 31, 2026, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended January 31, 2026 and the financial highlights for each of the five years in the period ended January 31, 2026 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of January 31, 2026 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 20, 2026
We have served as the auditor of one or more investment companies in The Vanguard Group of Funds since 1975.
11

 


Tax information (unaudited)
For corporate shareholders, 56.1%, or if subsequently determined to be different, the maximum percentage allowable by law, of ordinary income (dividend income plus short-term gains, if any) for the fiscal year qualified for the dividends-received deduction.
The fund hereby designates $739,361,000, or if subsequently determined to be different, the maximum amount allowable by law, as qualified dividend income for purposes of the maximum rate under section 1(h)(11) for calendar year 2025.
For nonresident alien shareholders, 100% of short-term capital gain dividends distributed by the fund for the fiscal year are qualified short-term capital gains.
The fund distributed $6,987,149,000 as capital gain dividends (20% rate gain distributions) to shareholders during the fiscal year.
Q570 032026
12
Financial Statements
For the year ended January 31, 2026
Vanguard Energy Fund

 

Contents
Financial Statements

1
Report of Independent Registered Public Accounting Firm

12
Tax information

13
   

 

Energy Fund
Financial Statements
Schedule of Investments
As of January 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov.
    Shares Market
Value

($000)
Common Stocks (98.9%)
Brazil (1.0%)
  Petroleo Brasileiro SA - Petrobras    8,669,425    66,535
Canada (0.9%)
  Cameco Corp.      459,493    56,697
France (11.5%)
  Engie SA (XPAR) 11,434,363   341,389
  TotalEnergies SE (TQEX)  3,560,565   258,955
  TotalEnergies SE (XNYS)  2,230,844   161,513
               761,857
Germany (2.4%)
  E.ON SE    7,670,579   162,692
India (2.0%)
  Reliance Industries Ltd.  5,529,089    84,014
  Power Grid Corp. of India Ltd. 17,441,407    48,688
               132,702
Italy (4.0%)
  Enel SpA 15,646,998   172,877
1 Tenaris SA ADR  1,742,938    77,212
  Tenaris SA    690,068    15,328
               265,417
Japan (1.2%)
  Kansai Electric Power Co. Inc.    4,937,678    78,780
Norway (1.0%)
  Equinor ASA  1,969,134    52,928
  Equinor ASA ADR    630,433    16,927
                69,855
Russia (0.0%)
*,2 LUKOIL PJSC ADR    1,423,477        —
Spain (1.8%)
  Iberdrola SA (XMAD)  5,306,110   119,296
* Iberdrola SA     72,686     1,630
               120,926
United Kingdom (12.1%)
  Shell plc (XLON)  8,679,164   333,623
  National Grid plc 12,527,184   212,831
  SSE plc  5,767,951   191,712
* Glencore plc  9,024,618    61,524
               799,690
United States (61.0%)
  Exxon Mobil Corp.  4,250,229   600,982
  Chevron Corp.  1,568,632   277,491
  Williams Cos. Inc.  4,024,053   270,658
  Marathon Petroleum Corp.  1,473,492   259,615
  Sempra  2,953,927   257,021
  Shell plc ADR  3,190,236   245,744
  Targa Resources Corp.  1,134,785   228,069
  Duke Energy Corp.  1,794,121   217,717
  Dominion Energy Inc.  3,588,930   215,946
  American Electric Power Co. Inc.  1,777,494   212,899
  Southern Co.  2,346,342   209,552
  Diamondback Energy Inc.  1,169,286   191,704
  NextEra Energy Inc.  2,173,817   191,079
  Coterra Energy Inc.  5,921,448   170,834
1

 

Energy Fund
    Shares Market
Value

($000)
  ONEOK Inc.  1,698,049   134,468
  Exelon Corp.  2,853,498   127,780
  Atmos Energy Corp.    689,729   114,730
  Constellation Energy Corp.    196,674    55,202
  SLB Ltd.    756,639    36,606
  Vistra Corp.    153,906    24,371
             4,042,468
Total Common Stocks (Cost $4,669,518) 6,557,619
Temporary Cash Investments (1.1%)
Money Market Fund (0.1%)
3,4 Vanguard Market Liquidity Fund, 3.704%      70,477     7,048
    Face
Amount
($000)
 
Repurchase Agreement (1.0%)
  NatWest Markets plc, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $67,521, collateralized by U.S. Treasury Obligations 3.750%, 11/30/2032, with a value of $68,850) 
    67,500    67,500
Total Temporary Cash Investments (Cost $74,548) 74,548
Total Investments (100.0%) (Cost $4,744,066) 6,632,167
Other Assets and Liabilities—Net (0.0%) (1,260)
Net Assets (100%) 6,630,907
Cost is in $000.
See Note A in Notes to Financial Statements.
* Non-income-producing security.
1 Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $6,729.
2 Security value determined using significant unobservable inputs.
3 Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
4 Collateral of $6,987 was received for securities on loan.
  ADR—American Depositary Receipt.
  
See accompanying Notes, which are an integral part of the Financial Statements.
2

 

Energy Fund
Statement of Assets and Liabilities
As of January 31, 2026
($000s, except shares and per-share amounts) Amount
Assets  
Investments in Securities, at Value1  
Unaffiliated Issuers (Cost $4,737,018) 6,625,119
Affiliated Issuers (Cost $7,048) 7,048
Total Investments in Securities 6,632,167
Investment in Vanguard 145
Cash 113
Foreign Currency, at Value (Cost $7,310) 7,348
Receivables for Accrued Income 6,205
Receivables for Capital Shares Issued 5,880
Total Assets 6,651,858
Liabilities  
Collateral for Securities on Loan 6,987
Payables to Investment Advisor 3,085
Payables for Capital Shares Redeemed 3,929
Payables to Vanguard 620
Deferred Foreign Capital Gains Taxes 6,330
Total Liabilities 20,951
Net Assets 6,630,907
1 Includes $6,729 of securities on loan.  
At January 31, 2026, net assets consisted of:  
   
Paid-in Capital 4,527,401
Total Distributable Earnings (Loss) 2,103,506
Net Assets 6,630,907
 
Investor Shares—Net Assets  
Applicable to 36,423,536 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
1,954,337
Net Asset Value Per Share—Investor Shares $53.66
 
Admiral™ Shares—Net Assets  
Applicable to 46,458,826 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
4,676,570
Net Asset Value Per Share—Admiral Shares $100.66
  
See accompanying Notes, which are an integral part of the Financial Statements.
3

 

Energy Fund
Statement of Operations
  Year Ended
January 31, 2026
  ($000)
Investment Income  
Income  
Dividends1 210,956
Non-Cash Dividends 15,448
Interest 1,848
Securities Lending—Net 56
Total Income 228,308
Expenses  
Investment Advisory Fees—Note B  
Basic Fee 8,985
Performance Adjustment 2,901
The Vanguard Group—Note C  
Management and Administrative—Investor Shares 4,242
Management and Administrative—Admiral Shares 6,249
Marketing and Distribution—Investor Shares 86
Marketing and Distribution—Admiral Shares 160
Custodian Fees 82
Auditing Fees 33
Shareholders’ Reports and Proxy Fees—Investor Shares 42
Shareholders’ Reports and Proxy Fees—Admiral Shares 28
Trustees’ Fees and Expenses 4
Other Expenses 396
Total Expenses 23,208
Expenses Paid Indirectly (23)
Net Expenses 23,185
Net Investment Income 205,123
Realized Net Gain (Loss)  
Investment Securities Sold2,3 320,315
Foreign Currencies 671
Realized Net Gain (Loss) 320,986
Change in Unrealized Appreciation (Depreciation)  
Investment Securities2,4 944,990
Foreign Currencies 481
Change in Unrealized Appreciation (Depreciation) 945,471
Net Increase (Decrease) in Net Assets Resulting from Operations 1,471,580
1 Dividends are net of foreign withholding taxes of $2,977.
2 Realized net gain (loss) and change in unrealized appreciation (depreciation) from an affiliated company of the fund were ($1) and less than $1, respectively. Purchases and sales are for temporary cash investment purposes.
3 Realized gain (loss) is net of foreign capital gain taxes of $350.
4 The change in unrealized appreciation (depreciation) is net of the change in deferred foreign capital gains taxes of ($2,334).
  
See accompanying Notes, which are an integral part of the Financial Statements.
4

 

Energy Fund
Statement of Changes in Net Assets
  Year Ended January 31,
  2026
($000)
2025
($000)
Increase (Decrease) in Net Assets    
Operations    
Net Investment Income 205,123 211,468
Realized Net Gain (Loss) 320,986 567,522
Change in Unrealized Appreciation (Depreciation) 945,471 74,309
Net Increase (Decrease) in Net Assets Resulting from Operations 1,471,580 853,299
Distributions    
Investor Shares (81,652) (302,919)
Admiral Shares (199,527) (632,375)
Total Distributions (281,179) (935,294)
Capital Share Transactions    
Investor Shares (228,060) 63,947
Admiral Shares 86,706 200,311
Net Increase (Decrease) from Capital Share Transactions (141,354) 264,258
Total Increase (Decrease) 1,049,047 182,263
Net Assets    
Beginning of Period 5,581,860 5,399,597
End of Period 6,630,907 5,581,860
  
See accompanying Notes, which are an integral part of the Financial Statements.
5

 

Energy Fund
Financial Highlights
Investor Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $44.04 $45.21 $46.43 $41.64 $31.66
Investment Operations          
Net Investment Income1 1.646 1.771 1.878 2.099 1.364
Net Realized and Unrealized Gain (Loss) on Investments 10.310 5.270 .080 4.807 10.019
Total from Investment Operations 11.956 7.041 1.958 6.906 11.383
Distributions          
Dividends from Net Investment Income (1.689) (1.685) (1.952) (2.116) (1.403)
Distributions from Realized Capital Gains (.647) (6.526) (1.226)
Total Distributions (2.336) (8.211) (3.178) (2.116) (1.403)
Net Asset Value, End of Period $53.66 $44.04 $45.21 $46.43 $41.64
Total Return2 27.60% 16.24% 4.00% 16.72% 36.33%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $1,954 $1,815 $1,775 $1,950 $1,771
Ratio of Total Expenses to Average Net Assets3 0.45%4 0.45%5 0.44%5 0.46%5 0.41%
Ratio of Net Investment Income to Average Net Assets 3.41% 3.62% 4.02% 4.70% 3.68%
Portfolio Turnover Rate 19% 36% 29% 16% 14%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
4 The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.45%.
5 The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.45%, 0.44% and 0.46% respectively.
  
See accompanying Notes, which are an integral part of the Financial Statements.
6

 

Energy Fund
Financial Highlights
Admiral Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $82.62 $84.83 $87.12 $78.12 $59.39
Investment Operations          
Net Investment Income1 3.156 3.392 3.599 4.014 2.615
Net Realized and Unrealized Gain (Loss) on Investments 19.345 9.886 .145 9.026 18.794
Total from Investment Operations 22.501 13.278 3.744 13.040 21.409
Distributions          
Dividends from Net Investment Income (3.246) (3.238) (3.733) (4.040) (2.679)
Distributions from Realized Capital Gains (1.215) (12.250) (2.301)
Total Distributions (4.461) (15.488) (6.034) (4.040) (2.679)
Net Asset Value, End of Period $100.66 $82.62 $84.83 $87.12 $78.12
Total Return2 27.70% 16.33% 4.09% 16.83% 36.43%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $4,677 $3,767 $3,625 $4,176 $3,608
Ratio of Total Expenses to Average Net Assets3 0.37%4 0.37%5 0.36%5 0.38%5 0.33%
Ratio of Net Investment Income to Average Net Assets 3.48% 3.69% 4.11% 4.78% 3.76%
Portfolio Turnover Rate 19% 36% 29% 16% 14%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 Includes performance-based investment advisory fee increases (decreases) of 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
4 The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.37%.
5 The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.36%, and 0.38% respectively.
  
See accompanying Notes, which are an integral part of the Financial Statements.
7

 

Energy Fund
Notes to Financial Statements
Vanguard Energy Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: Investor Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors.
In February 2026, the Board of Trustees approved changing the fund’s name to Vanguard Energy Opportunities Fund to better reflect its existing investment strategy, which will become effective in May 2026.
A. The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund’s pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund’s pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund’s tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund’s tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund’s financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund’s regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund’s board of trustees and included in Management and Administrative expenses on the fund’s Statement of Operations. Any borrowings under either facility bear interest at an agreed-upon spread plus the
8

 

Energy Fund
higher of the federal funds effective rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate inclusive of an additional agreed-upon spread. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the “Order”) from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund’s investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day’s notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the year ended January 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Taxes on foreign dividends and capital gains have been provided for in accordance with the applicable countries' tax rules and rates. Deferred foreign capital gains tax, if any, is accrued daily based upon net unrealized gains. The fund has filed tax reclaims for previously withheld taxes on dividends earned in certain European Union countries. These filings are subject to various administrative and judicial proceedings within these countries. Amounts related to these reclaims are recorded when there are no significant uncertainties as to the ultimate resolution of proceedings, the likelihood of receipt of these reclaims, and the potential timing of payment. Such tax reclaims and related professional fees, if any, are included in dividend income and other expenses, respectively.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses), shareholder reporting, and proxy fees. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B. Wellington Management Company LLP provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund's performance relative to the MSCI ACWI Energy + Utilities Index for the preceding three years. For the year ended January 31, 2026, the investment advisory fee paid represented an effective annual basic rate of 0.15% of the fund’s average net assets, before a net increase of $2,901,000 (0.05%) based on performance.
C. In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At January 31, 2026, the fund had contributed to Vanguard capital in the amount of $145,000, representing less than 0.01% of the fund’s net assets and 0.06% of Vanguard’s capital received pursuant to the FSA. The fund’s trustees and officers are also directors and employees, respectively, of Vanguard.
D. The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. For the year ended January 31, 2026, these arrangements reduced the fund’s expenses by $23,000 (an annual rate of less than 0.01% of average net assets).
E. Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.
Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund’s own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund’s investments as of January 31, 2026, based on the inputs used to value them:
  Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments        
Assets        
Common Stocks—North and South America 4,165,700 4,165,700
Common Stocks—Other 255,652 2,136,267 2,391,919
Temporary Cash Investments 7,048 67,500 74,548
Total 4,428,400 2,203,767 6,632,167
9

 

Energy Fund
F. Permanent differences between book-basis and tax-basis components of net assets are reclassified among capital accounts in the financial statements to reflect their tax character. These reclassifications have no effect on net assets or net asset value per share. Examples of permanent differences include, but are not limited to, the accounting for passive foreign investment companies, in-kind redemptions, swap agreements, and distributions in connection with fund share redemptions.
Permanent differences were reclassified between the following accounts: Amount
($000)
Paid-in Capital 21,869
Total Distributable Earnings (Loss) (21,869)
Temporary differences between book-basis and tax-basis components of total distributable earnings (loss) arise when certain items of income, gain, or loss are recognized in different periods for financial statement and tax purposes; these differences will reverse at some time in the future. Examples of temporary differences include, but are not limited to, capital loss carryforwards, the deferral of losses from wash sales, the recognition of unrealized gains or losses from certain derivative contracts, and the recognition of unrealized gains from passive foreign investment companies. As of period end, the tax-basis components of total distributable earnings (loss) are detailed in the table as follows:
  Amount
($000)
Undistributed Ordinary Income 29,305
Undistributed Long-Term Gains 197,950
Net Unrealized Gains (Losses) 1,877,190
Capital Loss Carryforwards
Qualified Late-Year Losses
Other Temporary Differences (939)
Total 2,103,506
The tax character of distributions paid was as follows:
  Year Ended January 31,
  2026
Amount
($000)
2025
Amount
($000)
Ordinary Income* 217,362 239,286
Long-Term Capital Gains 63,817 696,008
Total 281,179 935,294
* Includes short-term capital gains, if any.
As of January 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows:
  Amount
($000)
Tax Cost 4,748,899
Gross Unrealized Appreciation 2,001,493
Gross Unrealized Depreciation (118,225)
Net Unrealized Appreciation (Depreciation) 1,883,268
G. During the year ended January 31, 2026, the fund purchased $1,116,425,000 of investment securities and sold $1,376,796,000 of investment securities, other than temporary cash investments.
H. Capital share transactions for each class of shares were:
    
  Year Ended January 31,
  2026   2025
  Amount
($000)
Shares
(000)
  Amount
($000)
Shares
(000)
Investor Shares          
Issued 245,956 5,073   214,420 4,391
Issued in Lieu of Cash Distributions 75,412 1,526   280,497 6,405
Redeemed (549,428) (11,379)   (430,970) (8,851)
Net Increase (Decrease)—Investor Shares (228,060) (4,780)   63,947 1,945
10

 

Energy Fund
  Year Ended January 31,
  2026   2025
  Amount
($000)
Shares
(000)
  Amount
($000)
Shares
(000)
Admiral Shares          
Issued 598,680 6,585   362,906 3,968
Issued in Lieu of Cash Distributions 178,110 1,921   564,955 6,879
Redeemed (690,084) (7,644)   (727,550) (7,980)
Net Increase (Decrease)—Admiral Shares 86,706 862   200,311 2,867
I. Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance.
To the extent the fund’s investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
J. Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their operating results regularly reviewed by a chief operating decision maker (“CODM”). The fund is considered a single segment. Vanguard’s chief executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund’s chief financial officer collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund’s daily operations. Through these committees, the CODM manages the fund’s operations to achieve a single investment objective, as detailed in its prospectus, through the execution of the fund’s investment strategies. When assessing segment performance and making decisions about segment resources, the CODM relies on the fund’s portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the information contained in the fund’s financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying financial statements.
K. Management has determined that no other subsequent events or transactions occurred through the date the financial statements were issued that would require recognition or disclosure in these financial statements.
11

 

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Vanguard Specialized Funds and Shareholders of Vanguard Energy Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Vanguard Energy Fund (one of the funds constituting Vanguard Specialized Funds, referred to hereafter as the "Fund") as of January 31, 2026, the related statement of operations for the year ended January 31, 2026, the statement of changes in net assets for each of the two years in the period ended January 31, 2026, including the related notes, and the financial highlights for each of the five years in the period ended January 31, 2026 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of January 31, 2026, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended January 31, 2026 and the financial highlights for each of the five years in the period ended January 31, 2026 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of January 31, 2026 by correspondence with the custodian, transfer agent and broker. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 20, 2026
We have served as the auditor of one or more investment companies in The Vanguard Group of Funds since 1975.
12

 


Tax information (unaudited)
For corporate shareholders, 51.8%, or if subsequently determined to be different, the maximum percentage allowable by law, of ordinary income (dividend income plus short-term gains, if any) for the fiscal year qualified for the dividends-received deduction.
The fund hereby designates $217,313,000, or if subsequently determined to be different, the maximum amount allowable by law, as qualified dividend income for purposes of the maximum rate under section 1(h)(11) for calendar year 2025.
For nonresident alien shareholders, 100% of short-term capital gain dividends distributed by the fund for the fiscal year are qualified short-term capital gains.
The fund distributed $75,175,000 as capital gain dividends (20% rate gain distributions) to shareholders during the fiscal year.
Q510 032026
13
Financial Statements
For the year ended January 31, 2026
Vanguard Health Care Fund

 

Contents
Financial Statements

1
Report of Independent Registered Public Accounting Firm

14
Tax information

15
   

 

Health Care Fund
Financial Statements
Schedule of Investments
As of January 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov.
    Shares Market
Value

($000)
Common Stocks (97.5%)
Belgium (4.8%)
* Argenx SE  1,165,992    980,565
  UCB SA  3,023,965    921,479
              1,902,044
China (0.8%)
* Duality Biotherapeutics Inc.  2,771,377    117,021
* Jiangsu Hengrui Pharmaceuticals Co. Ltd. Class H  9,939,973     87,135
* Zai Lab Ltd. 36,431,700     60,568
  Shandong Weigao Group Medical Polymer Co. Ltd. Class H 77,092,000     49,360
* GenFleet Therapeutics Shanghai Inc. Class H  1,979,400      7,793
                321,877
Denmark (2.3%)
* Genmab A/S  1,345,944    438,489
* Ascendis Pharma A/S ADR  1,103,469    249,494
  Novo Nordisk A/S Class B  3,482,834    206,808
                894,791
Japan (5.2%)
  Otsuka Holdings Co. Ltd.  7,893,800    472,589
  Chugai Pharmaceutical Co. Ltd.  7,912,642    451,976
  Shionogi & Co. Ltd. 18,640,349    383,790
  Daiichi Sankyo Co. Ltd. 18,367,566    336,487
  Eisai Co. Ltd.  8,514,317    237,374
  Astellas Pharma Inc.  7,516,478    104,553
  M3 Inc.  5,441,953     67,148
              2,053,917
Switzerland (4.1%)
  Novartis AG (Registered)  3,795,144    563,085
  Roche Holding AG  1,206,949    548,848
  Galderma Group AG  2,623,305    488,981
              1,600,914
United Kingdom (8.8%)
  AstraZeneca plc 11,579,638  2,157,450
  GSK plc 45,301,487  1,171,571
*,1,2 Immunocore Holdings plc ADR  3,657,808    119,062
              3,448,083
United States (71.5%)
  Eli Lilly & Co.  3,696,560  3,833,887
  Merck & Co. Inc. 18,111,825  1,997,191
  UnitedHealth Group Inc.  4,772,250  1,369,302
  Johnson & Johnson  5,367,039  1,219,660
* Edwards Lifesciences Corp. 14,972,830  1,218,189
  Danaher Corp.  4,836,473  1,058,656
  Abbott Laboratories  9,621,496  1,051,630
* Intuitive Surgical Inc.  1,944,873    980,644
  Cencora Inc.  2,582,479    927,678
  AbbVie Inc.  4,034,908    899,825
  Medtronic plc  7,813,493    804,477
* Vertex Pharmaceuticals Inc.  1,589,663    746,983
  CVS Health Corp.  9,756,578    727,060
  Elevance Health Inc.  1,879,405    649,785
  Cardinal Health Inc.  2,840,801    610,431
* Biogen Inc.  2,913,639    524,135
  Agilent Technologies Inc.  3,480,187    465,823
  HCA Healthcare Inc.    933,410    455,756
* Alnylam Pharmaceuticals Inc.  1,309,033    442,532
* United Therapeutics Corp.    892,079    418,822
  Thermo Fisher Scientific Inc.    702,318    406,368
* Boston Scientific Corp.  4,128,084    386,100
1

 

Health Care Fund
    Shares Market
Value

($000)
* Dexcom Inc.  4,655,231    340,018
* Ionis Pharmaceuticals Inc.  3,803,181    314,409
  Stryker Corp.    748,338    276,556
  QIAGEN NV  5,130,344    275,346
  STERIS plc  1,012,472    265,875
* Cytokinetics Inc.  4,050,667    255,962
  Bristol-Myers Squibb Co.  4,606,141    253,568
* Structure Therapeutics Inc. ADR  2,811,254    248,655
  Regeneron Pharmaceuticals Inc.    318,062    235,827
* Revolution Medicines Inc.  2,383,815    231,111
* ICON plc  1,247,597    224,879
* Avantor Inc. 20,480,758    223,650
* Vaxcyte Inc.  3,653,768    195,732
* Madrigal Pharmaceuticals Inc.    398,129    194,808
* CG oncology Inc.  3,484,986    181,394
* Kymera Therapeutics Inc.  2,449,438    178,050
* Crinetics Pharmaceuticals Inc.  3,494,255    174,503
  Bio-Techne Corp.  2,720,122    174,333
*,1 Apellis Pharmaceuticals Inc.  7,632,548    172,343
* Option Care Health Inc.  4,987,675    169,581
* Incyte Corp.  1,590,914    159,203
* Alignment Healthcare Inc.  6,972,595    157,093
* PTC Therapeutics Inc.  2,038,232    153,948
  Encompass Health Corp.  1,600,016    151,249
* Apogee Therapeutics Inc.  2,251,282    147,481
* Natera Inc.    636,032    147,012
* Xenon Pharmaceuticals Inc.  3,546,755    145,452
*,2 Newamsterdam Pharma Co. NV  3,953,142    123,022
* Scholar Rock Holding Corp.  2,750,253    121,946
*,1 Acadia Healthcare Co. Inc.  8,815,704    118,483
*,1 Celldex Therapeutics Inc.  4,764,728    117,212
* Nuvalent Inc. Class A  1,054,377    108,485
* Protagonist Therapeutics Inc.  1,180,839     96,593
* Soleno Therapeutics Inc.  2,417,215     93,208
* Arcus Biosciences Inc.  4,124,859     86,787
* Dianthus Therapeutics Inc.  1,574,735     84,075
* Inspire Medical Systems Inc.  1,094,019     82,905
*,2 HeartFlow Inc.  2,256,545     67,403
* Immunome Inc.  2,152,764     53,001
* Mineralys Therapeutics Inc.  1,215,766     37,555
*,2 Aktis Oncology Inc.  1,523,479     30,850
             28,064,497
Total Common Stocks (Cost $22,573,619) 38,286,123
Temporary Cash Investments (2.2%)
Money Market Fund (0.1%)
3,4 Vanguard Market Liquidity Fund, 3.704%     587,800     58,780
    Face
Amount
($000)
 
Repurchase Agreements (2.1%)
  Bank of America Securities, LLC, 3.670%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $50,015, collateralized by U.S. Treasury Obligations 0.875%–4.625%, 6/30/2026–5/15/2053, with a value of $51,000) 
    50,000     50,000
  Bank of America Securities, LLC, 3.670%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $72,922, collateralized by U.S. Government Agency Obligations 2.000%–6.000%, 1/1/2029–7/1/2055, with a value of $74,358) 
    72,900     72,900
  Bank of America Securities, LLC, 3.680%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $115,035, collateralized by U.S. Government Agency Obligations 3.500%, 5/1/2052, with a value of $117,300) 
   115,000    115,000
  Bank of Nova Scotia, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $94,029, collateralized by U.S. Treasury Obligations 0.000%–4.875%, 3/15/2026–5/15/2052, with a value of $95,909) 
    94,000     94,000
  Barclays Capital Inc., 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $53,516, collateralized by U.S. Treasury Obligations 2.875%, 4/30/2029, with a value of $54,570) 
    53,500     53,500
  BNP Paribas Securities Corp., 3.650%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $10,003, collateralized by U.S. Treasury Obligations 0.000%–4.250%, 4/9/2026–8/15/2054, with a value of $10,200) 
    10,000     10,000
2

 

Health Care Fund
    Face
Amount
($000)
Market
Value

($000)
  BNP Paribas Securities Corp., 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $120,337, collateralized by U.S. Treasury and Government Agency Obligations 0.625%–7.000%, 3/1/2027–2/1/2056, with a value of $122,706) 
   120,300    120,300
  Credit Agricole Securities, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $8,102, collateralized by U.S. Treasury Obligations 3.000%, 2/15/2047, with a value of $8,262) 
     8,100      8,100
  HSBC Bank USA, 3.670%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $34,010, collateralized by U.S. Treasury Obligations 1.875%, 2/15/2051, with a value of $34,680) 
    34,000     34,000
  HSBC Bank USA, 3.680%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $15,505, collateralized by U.S. Government Agency Obligations 2.000%–6.500%, 1/1/2030–1/1/2055, with a value of $15,810) 
    15,500     15,500
  JP Morgan Securities, LLC, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $70,021, collateralized by U.S. Treasury Obligations 0.000%, 7/30/2026, with a value of $71,400) 
    70,000     70,000
  Natixis SA, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $71,122, collateralized by U.S. Treasury and Government Agency Obligations 0.375%–4.125%, 10/31/2026–2/15/2054, with a value of $72,522) 
    71,100     71,100
  Nomura International plc, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $10,803, collateralized by U.S. Treasury Obligations 1.125%–4.250%, 1/15/2028–2/15/2031, with a value of $11,027) 
    10,800     10,800
  Nomura International plc, 3.660%, 2/2/2026
(Dated 1/30/2026, Repurchase Value $80,024, collateralized by U.S. Treasury Obligations 3.375%–3.772%, 7/31/2027–11/30/2027, with a value of $81,600) 
    80,000     80,000
                805,200
Total Temporary Cash Investments (Cost $863,980) 863,980
Total Investments (99.7%) (Cost $23,437,599) 39,150,103
Other Assets and Liabilities—Net (0.3%) 113,715
Net Assets (100%) 39,263,818
Cost is in $000.
See Note A in Notes to Financial Statements.
* Non-income-producing security.
1 Considered an affiliated company of the fund as the fund owns more than 5% of the outstanding voting securities of such company.
2 Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $55,126.
3 Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
4 Collateral of $58,726 was received for securities on loan.
  ADR—American Depositary Receipt.
  
See accompanying Notes, which are an integral part of the Financial Statements.
3

 

Health Care Fund
Statement of Assets and Liabilities
As of January 31, 2026
($000s, except shares and per-share amounts) Amount
Assets  
Investments in Securities, at Value1  
Unaffiliated Issuers (Cost $22,539,821) 38,564,223
Affiliated Issuers (Cost $897,778) 585,880
Total Investments in Securities 39,150,103
Investment in Vanguard 936
Cash 96
Foreign Currency, at Value (Cost $2,786) 2,933
Receivables for Investment Securities Sold 177,369
Receivables for Accrued Income 118,970
Receivables for Capital Shares Issued 2,037
Total Assets 39,452,444
Liabilities  
Payables for Investment Securities Purchased 100,994
Collateral for Securities on Loan 58,726
Payables to Investment Advisor 14,486
Payables for Capital Shares Redeemed 12,000
Payables to Vanguard 2,420
Total Liabilities 188,626
Net Assets 39,263,818
1 Includes $55,126 of securities on loan.  
At January 31, 2026, net assets consisted of:  
   
Paid-in Capital 22,149,628
Total Distributable Earnings (Loss) 17,114,190
Net Assets 39,263,818
 
Investor Shares—Net Assets  
Applicable to 28,088,282 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
5,748,994
Net Asset Value Per Share—Investor Shares $204.68
 
Admiral™ Shares—Net Assets  
Applicable to 388,363,070 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
33,514,824
Net Asset Value Per Share—Admiral Shares $86.30
  
See accompanying Notes, which are an integral part of the Financial Statements.
4

 

Health Care Fund
Statement of Operations
  Year Ended
January 31, 2026
  ($000)
Investment Income  
Income  
Dividends—Unaffiliated Issuers1 503,217
Dividends—Affiliated Issuers2 11,251
Interest—Unaffiliated Issuers 39,022
Securities Lending—Net 1,325
Total Income 554,815
Expenses  
Investment Advisory Fees—Note B  
Basic Fee 54,658
Performance Adjustment (2,227)
The Vanguard Group—Note C  
Management and Administrative—Investor Shares 10,151
Management and Administrative—Admiral Shares 39,628
Marketing and Distribution—Investor Shares 237
Marketing and Distribution—Admiral Shares 954
Custodian Fees 918
Auditing Fees 32
Shareholders’ Reports and Proxy Fees—Investor Shares 176
Shareholders’ Reports and Proxy Fees—Admiral Shares 173
Trustees’ Fees and Expenses 22
Other Expenses 66
Total Expenses 104,788
Expenses Paid Indirectly (23)
Net Expenses 104,765
Net Investment Income 450,050
Realized Net Gain (Loss)  
Investment Securities Sold—Unaffiliated Issuers 3,331,725
Investment Securities Sold—Affiliated Issuers (1,200,004)
Foreign Currencies 1,393
Realized Net Gain (Loss) 2,133,114
Change in Unrealized Appreciation (Depreciation)  
Investment Securities—Unaffiliated Issuers 159,458
Investment Securities—Affiliated Issuers 1,085,844
Foreign Currencies 12,872
Change in Unrealized Appreciation (Depreciation) 1,258,174
Net Increase (Decrease) in Net Assets Resulting from Operations 3,841,338
1 Dividends are net of foreign withholding taxes of $17,773.
2 Dividends are net of foreign withholding taxes of $1,250.
  
See accompanying Notes, which are an integral part of the Financial Statements.
5

 

Health Care Fund
Statement of Changes in Net Assets
  Year Ended January 31,
  2026
($000)
2025
($000)
Increase (Decrease) in Net Assets    
Operations    
Net Investment Income 450,050 392,772
Realized Net Gain (Loss) 2,133,114 4,074,010
Change in Unrealized Appreciation (Depreciation) 1,258,174 (3,058,415)
Net Increase (Decrease) in Net Assets Resulting from Operations 3,841,338 1,408,367
Distributions    
Investor Shares (261,878) (769,293)
Admiral Shares (1,510,572) (4,238,323)
Total Distributions (1,772,450) (5,007,616)
Capital Share Transactions    
Investor Shares (964,124) (327,718)
Admiral Shares (3,747,907) (459,595)
Net Increase (Decrease) from Capital Share Transactions (4,712,031) (787,313)
Total Increase (Decrease) (2,643,143) (4,386,562)
Net Assets    
Beginning of Period 41,906,961 46,293,523
End of Period 39,263,818 41,906,961
  
See accompanying Notes, which are an integral part of the Financial Statements.
6

 

Health Care Fund
Financial Highlights
Investor Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $192.16 $210.61 $212.59 $210.54 $218.60
Investment Operations          
Net Investment Income1 2.125 1.733 1.789 1.654 1.869
Net Realized and Unrealized Gain (Loss) on Investments 19.194 3.617 11.217 11.988 8.949
Total from Investment Operations 21.319 5.350 13.006 13.642 10.818
Distributions          
Dividends from Net Investment Income (2.117) (1.809) (1.751) (1.659) (1.951)
Distributions from Realized Capital Gains (6.682) (21.991) (13.235) (9.933) (16.927)
Total Distributions (8.799) (23.800) (14.986) (11.592) (18.878)
Net Asset Value, End of Period $204.68 $192.16 $210.61 $212.59 $210.54
Total Return2 11.39% 2.96% 6.43% 6.57% 4.48%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $5,749 $6,428 $7,297 $7,496 $7,493
Ratio of Total Expenses to Average Net Assets3 0.33%4 0.37%5 0.35%5 0.34%5 0.30%
Ratio of Net Investment Income to Average Net Assets 1.15% 0.81% 0.86% 0.80% 0.82%
Portfolio Turnover Rate 47% 29% 16% 19% 15%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 Includes performance-based investment advisory fee increases (decreases) of (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
4 The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.33%.
5 The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.35% and 0.34% respectively.
  
See accompanying Notes, which are an integral part of the Financial Statements.
7

 

Health Care Fund
Financial Highlights
Admiral Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $81.02 $88.81 $89.64 $88.77 $92.17
Investment Operations          
Net Investment Income1 .940 .772 .796 .750 .830
Net Realized and Unrealized Gain (Loss) on Investments 8.099 1.523 4.738 5.052 3.780
Total from Investment Operations 9.039 2.295 5.534 5.802 4.610
Distributions          
Dividends from Net Investment Income (.941) (.810) (.782) (.743) (.870)
Distributions from Realized Capital Gains (2.818) (9.275) (5.582) (4.189) (7.140)
Total Distributions (3.759) (10.085) (6.364) (4.932) (8.010)
Net Asset Value, End of Period $86.30 $81.02 $88.81 $89.64 $88.77
Total Return2 11.46% 3.01% 6.48% 6.63% 4.53%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $33,515 $35,479 $38,997 $39,981 $39,934
Ratio of Total Expenses to Average Net Assets3 0.27%4 0.32%5 0.30%5 0.29%5 0.25%
Ratio of Net Investment Income to Average Net Assets 1.20% 0.85% 0.90% 0.86% 0.86%
Portfolio Turnover Rate 47% 29% 16% 19% 15%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 Includes performance-based investment advisory fee increases (decreases) of (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
4 The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.27%.
5 The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.32%, 0.30%, and 0.29% respectively.
  
See accompanying Notes, which are an integral part of the Financial Statements.
8

 

Health Care Fund
Notes to Financial Statements
Vanguard Health Care Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: Investor Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors.
A. The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund’s pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund’s pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund’s tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund’s tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund’s financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund’s regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund’s board of trustees and included in Management and Administrative expenses on the fund’s Statement of Operations. Any borrowings under either facility bear interest at an agreed-upon spread plus the higher of the federal funds effective rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate inclusive of an additional agreed-upon spread. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
9

 

Health Care Fund
In accordance with an exemptive order (the “Order”) from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund’s investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day’s notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the year ended January 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Premiums and discounts on debt securities are amortized and accreted, respectively, to interest income over the lives of the respective securities, except for premiums on certain callable debt securities that are amortized to the earliest call date. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Taxes on foreign dividends and capital gains have been provided for in accordance with the applicable countries' tax rules and rates. Deferred foreign capital gains tax, if any, is accrued daily based upon net unrealized gains. The fund has filed tax reclaims for previously withheld taxes on dividends earned in certain European Union countries. These filings are subject to various administrative and judicial proceedings within these countries. Amounts related to these reclaims are recorded when there are no significant uncertainties as to the ultimate resolution of proceedings, the likelihood of receipt of these reclaims, and the potential timing of payment. Such tax reclaims and related professional fees, if any, are included in dividend income and other expenses, respectively.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses), shareholder reporting, and proxy fees. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B. Wellington Management Company LLP provides investment advisory services to the fund for a fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund’s performance relative to the MSCI All Country World Health Care Index for the preceding three years. For the year ended January 31, 2026, the investment advisory fee represented an effective annual basic rate of 0.15% of the fund’s average net assets, before a net decrease of $2,227,000 (0.01%) based on performance.
C. In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At January 31, 2026, the fund had contributed to Vanguard capital in the amount of $936,000, representing less than 0.01% of the fund’s net assets and 0.37% of Vanguard’s capital received pursuant to the FSA. The fund’s trustees and officers are also directors and employees, respectively, of Vanguard.
D. The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund’s management and administrative expenses. For the year ended January 31, 2026, these arrangements reduced the fund’s expenses by $23,000 (an annual rate of less than 0.01% of average net assets).
E. Various inputs may be used to determine the value of the fund’s investments. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.
Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund’s own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund’s investments as of January 31, 2026, based on the inputs used to value them:
  Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments        
Assets        
Common Stocks—North and South America 28,064,497 28,064,497
Common Stocks—Other 368,556 9,853,070 10,221,626
Temporary Cash Investments 58,780 805,200 863,980
Total 28,491,833 10,658,270 39,150,103
10

 

Health Care Fund
F. Permanent differences between book-basis and tax-basis components of net assets are reclassified among capital accounts in the financial statements to reflect their tax character. These reclassifications have no effect on net assets or net asset value per share. Examples of permanent differences include, but are not limited to, the accounting for passive foreign investment companies, in-kind redemptions, swap agreements, and distributions in connection with fund share redemptions.
Permanent differences were reclassified between the following accounts: Amount
($000)
Paid-in Capital 40,621
Total Distributable Earnings (Loss) (40,621)
Temporary differences between book-basis and tax-basis components of total distributable earnings (loss) arise when certain items of income, gain, or loss are recognized in different periods for financial statement and tax purposes; these differences will reverse at some time in the future. Examples of temporary differences include, but are not limited to, capital loss carryforwards, the deferral of losses from wash sales, the recognition of unrealized gains or losses from certain derivative contracts, and the recognition of unrealized gains from passive foreign investment companies. As of period end, the tax-basis components of total distributable earnings (loss) are detailed in the table as follows:
  Amount
($000)
Undistributed Ordinary Income 30,442
Undistributed Long-Term Gains 1,422,371
Net Unrealized Gains (Losses) 15,661,377
Capital Loss Carryforwards
Qualified Late-Year Losses
Other Temporary Differences
Total 17,114,190
The tax character of distributions paid was as follows:
  Year Ended January 31,
  2026
Amount
($000)
2025
Amount
($000)
Ordinary Income* 465,740 805,080
Long-Term Capital Gains 1,306,710 4,202,536
Total 1,772,450 5,007,616
* Includes short-term capital gains, if any.
As of January 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows:
  Amount
($000)
Tax Cost 23,501,550
Gross Unrealized Appreciation 16,853,086
Gross Unrealized Depreciation (1,204,533)
Net Unrealized Appreciation (Depreciation) 15,648,553
G. During the year ended January 31, 2026, the fund purchased $17,266,085,000 of investment securities and sold $23,510,056,000 of investment securities, other than temporary cash investments.
The fund purchased securities from and sold securities to other funds or accounts managed by its investment advisor or their affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the year ended January 31, 2026, such purchases were $131,670,000 and sales were $16,244,000, resulting in net realized loss of $8,896,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
11

 

Health Care Fund
H. Capital share transactions for each class of shares were:
    
  Year Ended January 31,
  2026   2025
  Amount
($000)
Shares
(000)
  Amount
($000)
Shares
(000)
Investor Shares          
Issued 263,438 1,377   372,484 1,772
Issued in Lieu of Cash Distributions 246,441 1,274   723,569 3,812
Redeemed (1,474,003) (8,017)   (1,423,771) (6,775)
Net Increase (Decrease)—Investor Shares (964,124) (5,366)   (327,718) (1,191)
Admiral Shares          
Issued 667,798 8,521   715,793 8,003
Issued in Lieu of Cash Distributions 1,309,382 16,039   3,693,155 46,177
Redeemed (5,725,087) (74,113)   (4,868,543) (55,381)
Net Increase (Decrease)—Admiral Shares (3,747,907) (49,553)   (459,595) (1,201)
I. Certain of the fund’s investments were in companies that were considered to be affiliated companies of the fund because the fund owned more than 5% of the outstanding voting securities of the company or the issuer was another member of The Vanguard Group. Transactions during the period in securities of these companies were as follows:
    Current Period Transactions  
  Jan. 31,
2025
Market
Value
($000)
Purchases
at Cost
($000)
Proceeds
from
Securities
Sold
($000)
Realized
Net
Gain
(Loss)
($000)
Change in
Unrealized
App. (Dep.)
($000)
Income
($000)
Capital Gain
Distributions
Received
($000)
Jan. 31,
2026
Market
Value
($000)
Acadia Healthcare Co. Inc. 251,191 59,237 (191,945) 118,483
agilon health Inc. 110,486 132,251 (300,411) 322,176
Akero Therapeutics Inc. 220,096 36,740 247,970 94,375 (103,241)
Amicus Therapeutics Inc. 200,164 285,591 43,089 42,338
Apellis Pharmaceuticals Inc. 245,930 190,873 224,071 (131,271) 90,882 172,343
Apogee Therapeutics Inc. NA1 102,375 112,452 (11,102) 85,942 NA2
Autolus Therapeutics plc ADR 42,778 27,358 (65,884) 50,464
Celldex Therapeutics Inc. 111,392 86,829 64,051 (56,467) 39,509 117,212
Charles River Laboratories International Inc. NA1 52,769 427,222 (21,750) 66,829
Denali Therapeutics Inc. 185,735 39,831 155,458 (62,450) (7,658)
Eisai Co. Ltd. 460,003 196,848 (194,556) 168,775 11,251 NA3
Evolent Health Inc. Class A 70,833 63,710 (84,037) 76,914
Immunocore Holdings plc ADR 150,676 18,257 43,944 (47,023) 41,096 119,062
Prothena Corp. plc 60,044 20,158 (119,201) 79,315
Rocket Pharmaceuticals Inc. 81,598 27,180 (155,131) 100,713
Structure Therapeutics Inc. ADR 127,347 86,271 100,508 (88,190) 223,735 NA2
Vanguard Market Liquidity Fund 25,401 NA4 NA4 5 58,780
Total 2,343,674 673,182 2,128,772 (1,200,004) 1,085,844 11,251 585,880
1 Not applicable—at January 31, 2025, the issuer was not an affiliated company of the fund.
2 Not applicable—at January 31, 2026, and January 31, 2025, the issuer was not an affiliated company of the fund, but it was affiliated during the year.
3 Not applicable—at January 31, 2026, the issuer was not an affiliated company of the fund.
4 Not applicable—purchases and sales are for temporary cash investment purposes.
J. Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance.
To the extent the fund’s investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
K. Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their operating results regularly reviewed by a chief operating decision maker (“CODM”). The fund is considered a single segment. Vanguard’s chief executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund’s chief financial officer collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund’s daily operations. Through these committees, the CODM manages the fund’s operations to achieve a single investment objective, as detailed in its
12

 

Health Care Fund
prospectus, through the execution of the fund’s investment strategies. When assessing segment performance and making decisions about segment resources, the CODM relies on the fund’s portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the information contained in the fund’s financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying financial statements.
L. Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would require recognition or disclosure in these financial statements.
13

 

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Vanguard Specialized Funds and Shareholders of Vanguard Health Care Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Vanguard Health Care Fund (one of the funds constituting Vanguard Specialized Funds, referred to hereafter as the "Fund") as of January 31, 2026, the related statement of operations for the year ended January 31, 2026, the statement of changes in net assets for each of the two years in the period ended January 31, 2026, including the related notes, and the financial highlights for each of the five years in the period ended January 31, 2026 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of January 31, 2026, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended January 31, 2026 and the financial highlights for each of the five years in the period ended January 31, 2026 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of January 31, 2026 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 20, 2026
We have served as the auditor of one or more investment companies in The Vanguard Group of Funds since 1975.
14

 


Tax information (unaudited)
For corporate shareholders, 58.8%, or if subsequently determined to be different, the maximum percentage allowable by law, of ordinary income (dividend income plus short-term gains, if any) for the fiscal year qualified for the dividends-received deduction.
The fund hereby designates $465,715,000, or if subsequently determined to be different, the maximum amount allowable by law, as qualified dividend income for purposes of the maximum rate under section 1(h)(11) for calendar year 2025.
For nonresident alien shareholders, 100% of short-term capital gain dividends distributed by the fund for the fiscal year are qualified short-term capital gains.
The fund distributed $1,339,405,000 as capital gain dividends (20% rate gain distributions) to shareholders during the fiscal year.
Q520 032026
15
Financial Statements
For the year ended January 31, 2026
Vanguard Dividend Appreciation Index Fund

 

Contents
Financial Statements

1
Report of Independent Registered Public Accounting Firm

17
Tax information

18
   

 

Dividend Appreciation Index Fund
Financial Statements
Schedule of Investments
As of January 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund’s Form N-PORT reports are available on the SEC’s website at www.sec.gov.
    Shares Market
Value

($000)
Common Stocks (99.4%)
Communication Services (0.5%)
  Comcast Corp. Class A 20,164,076     599,881
* Versant Media Group Inc.    807,755      26,317
  John Wiley & Sons Inc. Class A    225,088       7,029
                 633,227
Consumer Discretionary (5.0%)
  Home Depot Inc.  5,462,546   2,046,215
  McDonald's Corp.  3,908,425   1,231,154
  Lowe's Cos. Inc.  3,092,333     825,838
  Starbucks Corp.  6,226,483     572,525
  NIKE Inc. Class B  6,579,778     406,696
  DR Horton Inc.  1,543,724     229,768
  Tractor Supply Co.  2,900,102     147,557
  Williams-Sonoma Inc.    685,978     140,385
  Genuine Parts Co.    763,685     106,144
  Dick's Sporting Goods Inc.    362,455      73,216
  Domino's Pizza Inc.    170,572      69,991
  Service Corp. International    771,079      62,018
  Pool Corp.    180,317      45,817
  Lithia Motors Inc.    132,948      43,001
  Churchill Downs Inc.    363,317      35,736
  Thor Industries Inc.    287,915      32,209
  Brunswick Corp.    357,518      28,680
  Graham Holdings Co. Class B     18,626      21,730
  Dillard's Inc. Class A     16,569      10,067
  Shoe Carnival Inc.     99,887       1,904
               6,130,651
Consumer Staples (10.0%)
  Walmart Inc. 24,080,007   2,868,892
  Costco Wholesale Corp.  2,427,687   2,282,633
  Procter & Gamble Co. 12,880,431   1,954,863
  Coca-Cola Co. 21,276,514   1,591,696
  PepsiCo Inc.  7,507,749   1,153,416
  Mondelez International Inc. Class A  7,323,240     428,190
  Colgate-Palmolive Co.  4,454,768     402,221
  Target Corp.  2,507,821     264,500
  Sysco Corp.  2,638,565     221,244
  Hershey Co.    813,362     158,402
  Kroger Co.  2,345,860     147,437
  Church & Dwight Co. Inc.  1,311,085     126,192
  Casey's General Stores Inc.    203,974     123,710
  Tyson Foods Inc. Class A  1,549,800     101,248
  McCormick & Co. Inc.  1,388,718      85,864
  Clorox Co.    673,121      75,921
  Ingredion Inc.    351,848      41,553
  Brown-Forman Corp. Class B  1,045,726      28,622
  Marzetti Co.    111,564      19,141
  WD-40 Co.     74,300      17,180
  Andersons Inc.    184,166      11,417
  J & J Snack Foods Corp.     85,701       8,142
  Brown-Forman Corp. Class A    230,480       6,414
  Tootsie Roll Industries Inc.    108,020       4,092
  Oil-Dri Corp. of America     56,681       3,432
              12,126,422
Energy (3.1%)
  Exxon Mobil Corp. 23,368,680   3,304,331
  Phillips 66  2,211,308     317,456
  Texas Pacific Land Corp.    317,812     110,713
1

 

Dividend Appreciation Index Fund
    Shares Market
Value

($000)
  DT Midstream Inc.    534,723      67,386
               3,799,886
Financials (21.1%)
  JPMorgan Chase & Co. 14,473,991   4,427,449
  Visa Inc. Class A  8,642,490   2,781,413
  Mastercard Inc. Class A  4,529,278   2,440,330
  Bank of America Corp. 36,184,964   1,925,040
  Goldman Sachs Group Inc.  1,603,453   1,499,886
  Morgan Stanley  6,645,402   1,214,780
  S&P Global Inc.  1,714,899     905,107
  Blackrock Inc.    791,915     886,105
  Chubb Ltd.  2,020,793     625,557
  CME Group Inc.  1,979,229     572,116
  Intercontinental Exchange Inc.  3,127,608     543,516
  Marsh & McLennan Cos. Inc.  2,689,176     506,076
  PNC Financial Services Group Inc.  2,156,891     481,634
  Bank of New York Mellon Corp.  3,876,895     464,917
  Moody's Corp.    847,664     437,022
  Aon plc Class A (XNYS)  1,179,694     412,468
  Travelers Cos. Inc.  1,225,814     348,756
  Arthur J Gallagher & Co.  1,384,375     345,222
  Aflac Inc.  2,615,371     290,175
  Allstate Corp.  1,435,309     285,612
  Ameriprise Financial Inc.    514,242     271,103
  MSCI Inc.    415,741     253,278
  Fifth Third Bancorp  4,941,960     248,185
  MetLife Inc.  3,052,032     240,744
  Nasdaq Inc.  2,475,436     239,845
  Hartford Insurance Group Inc.  1,540,914     208,116
  State Street Corp.  1,557,783     203,852
  Raymond James Financial Inc.    960,159     159,252
  Cboe Global Markets Inc.    574,423     152,257
  Cincinnati Financial Corp.    855,395     137,625
  Brown & Brown Inc.  1,612,716     116,277
  W R Berkley Corp.  1,652,027     113,296
  Principal Financial Group Inc.  1,097,081     103,916
  Fidelity National Financial Inc.  1,399,241      76,105
  RenaissanceRe Holdings Ltd.    267,014      75,218
  Evercore Inc. Class A    212,197      74,963
  Reinsurance Group of America Inc. Class A    360,687      73,129
  Jack Henry & Associates Inc.    397,662      71,265
  Unum Group    864,031      65,640
  Assurant Inc.    274,650      65,402
  Globe Life Inc.    436,713      61,236
  Southstate Bank Corp.    551,686      56,454
  Wintrust Financial Corp.    367,093      54,143
  FactSet Research Systems Inc.    205,152      52,182
  UMB Financial Corp.    391,551      49,782
  American Financial Group Inc.    379,611      49,452
  Old Republic International Corp.  1,248,932      48,921
  Zions Bancorp NA    809,906      48,521
  Cullen / Frost Bankers Inc.    350,060      48,245
  Primerica Inc.    175,055      46,046
  SEI Investments Co.    518,598      45,559
  Erie Indemnity Co. Class A    139,533      39,489
  Commerce Bancshares Inc.    712,172      37,489
  Prosperity Bancshares Inc.    522,032      36,025
  First American Financial Corp.    559,738      35,364
  MarketAxess Holdings Inc.    203,738      34,479
  Hanover Insurance Group Inc.    195,065      33,969
  RLI Corp.    503,999      29,449
  Home BancShares Inc.  1,002,970      28,986
  Selective Insurance Group Inc.    331,938      27,909
  Bank OZK    581,983      27,679
  Morningstar Inc.    130,772      26,428
  United Community Banks Inc.    665,855      22,925
  First Financial Bankshares Inc.    715,289      22,761
  ServisFirst Bancshares Inc.    275,677      22,564
  CNO Financial Group Inc.    530,844      22,322
2

 

Dividend Appreciation Index Fund
    Shares Market
Value

($000)
  Independent Bank Corp. (XNGS)    271,705      21,948
  International Bancshares Corp.    296,324      20,636
  Assured Guaranty Ltd.    238,068      20,200
  Community Financial System Inc.    288,435      18,027
  BOK Financial Corp.    121,388      15,773
  Towne Bank    402,027      14,071
  First Merchants Corp.    342,456      13,616
  NBT Bancorp Inc.    286,924      12,748
  BancFirst Corp.    113,067      12,432
  Enterprise Financial Services Corp.    203,738      11,684
  Stock Yards Bancorp Inc.    150,375      10,179
  Nelnet Inc. Class A     76,287      10,062
  Horace Mann Educators Corp.    223,060       9,995
  Cohen & Steers Inc.    151,794       9,754
  City Holding Co.     78,947       9,718
  TriCo Bancshares    178,180       8,877
  Federal Agricultural Mortgage Corp. Class C     51,603       8,736
  Lakeland Financial Corp.    140,146       8,353
  Westamerica BanCorp    136,549       6,907
  German American Bancorp Inc.    162,746       6,847
  Bank First Corp.     49,018       6,840
  1st Source Corp.    100,272       6,751
  First Mid Bancshares Inc.    120,071       5,055
  Mercantile Bank Corp.     89,331       4,643
  Cadence Bank    101,672       4,281
  Independent Bank Corp.    113,722       3,997
  AMERISAFE Inc.    104,144       3,917
  Republic Bancorp Inc. Class A     52,585       3,818
  First Community Bankshares Inc.    100,640       3,625
  Southern Missouri Bancorp Inc.     51,746       3,238
  Cass Information Systems Inc.     63,992       2,877
  Northrim BanCorp Inc.    121,359       2,859
  First Business Financial Services Inc.     45,751       2,622
  Unity Bancorp Inc.     36,234       1,955
              25,658,069
Health Care (16.3%)
  Eli Lilly & Co.  4,358,505   4,520,423
  Johnson & Johnson 13,225,628   3,005,524
  AbbVie Inc.  9,710,780   2,165,601
  Merck & Co. Inc. 13,606,130   1,500,348
  UnitedHealth Group Inc.  4,971,886   1,426,583
  Abbott Laboratories  9,544,397   1,043,203
  Amgen Inc.  2,957,943   1,011,262
  Danaher Corp.  3,461,390     757,664
  Medtronic plc  7,041,675     725,011
  Stryker Corp.  1,887,575     697,572
  McKesson Corp.    685,292     569,622
  Elevance Health Inc.  1,207,104     417,344
  Cencora Inc.  1,081,821     388,612
  Becton Dickinson & Co.  1,584,295     322,372
  Zoetis Inc.  2,434,057     303,819
  Cardinal Health Inc.  1,306,897     280,826
  ResMed Inc.    801,026     206,913
  STERIS plc    541,424     142,178
  Quest Diagnostics Inc.    614,992     115,022
  West Pharmaceutical Services Inc.    396,125      91,552
  Ensign Group Inc.    315,708      54,194
  Chemed Corp.     77,608      33,150
  National HealthCare Corp.     68,760       9,840
  LeMaitre Vascular Inc.    114,935       9,766
              19,798,401
Industrials (11.6%)
  Caterpillar Inc.  2,594,509   1,705,526
  Honeywell International Inc.  3,484,562     792,807
  Union Pacific Corp.  3,266,091     767,858
  Eaton Corp. plc  2,131,885     749,187
  Lockheed Martin Corp.  1,124,087     712,918
  Automatic Data Processing Inc.  2,223,366     548,771
  Northrop Grumman Corp.    741,344     513,203
3

 

Dividend Appreciation Index Fund
    Shares Market
Value

($000)
  General Dynamics Corp.  1,415,593     497,000
  Emerson Electric Co.  3,117,936     458,212
  Waste Management Inc.  2,034,452     452,137
  Cummins Inc.    755,854     437,503
  CSX Corp. 10,219,587     385,892
  Illinois Tool Works Inc.  1,458,084     380,939
  Cintas Corp.  1,873,769     358,621
  L3Harris Technologies Inc.  1,034,507     354,681
  Fastenal Co.  6,295,641     272,979
  Rockwell Automation Inc.    615,221     259,408
  WW Grainger Inc.    240,117     259,312
  Republic Services Inc.  1,106,118     237,915
  Comfort Systems USA Inc.    193,110     220,551
  Xylem Inc.  1,335,821     184,170
  Paychex Inc.  1,777,862     183,351
  Dover Corp.    752,580     151,637
  Hubbell Inc.    291,806     142,384
  Veralto Corp.  1,362,718     134,882
  Broadridge Financial Solutions Inc.    640,067     126,164
  CH Robinson Worldwide Inc.    645,656     125,871
  Expeditors International of Washington Inc.    735,743     118,116
  RB Global Inc. (XTSE)  1,018,869     115,713
  HEICO Corp. Class A    424,957     108,190
  Snap-on Inc.    286,116     104,750
  Pentair plc    897,922      94,614
  Huntington Ingalls Industries Inc.    215,488      90,615
  Lennox International Inc.    175,485      86,879
  ITT Inc.    466,925      85,120
  JB Hunt Transport Services Inc.    414,107      83,948
  IDEX Corp.    411,017      81,607
  Nordson Corp.    293,399      80,547
  Lincoln Electric Holdings Inc.    301,849      80,096
  Graco Inc.    909,540      79,430
  Carlisle Cos. Inc.    232,734      79,337
  Allegion plc    472,022      78,068
  Masco Corp.  1,160,928      76,726
  Watsco Inc.    191,869      74,148
  HEICO Corp.    219,608      72,670
  Donaldson Co. Inc.    636,733      64,909
  Advanced Drainage Systems Inc.    392,609      59,692
  Booz Allen Hamilton Holding Corp.    670,881      59,319
  Tetra Tech Inc.  1,433,856      53,999
  Owens Corning    450,553      53,994
  Applied Industrial Technologies Inc.    207,223      53,963
  Toro Co.    547,844      50,128
  Oshkosh Corp.    347,173      49,930
  A O Smith Corp.    628,201      46,166
  Watts Water Technologies Inc. Class A    150,309      44,989
  Ryder System Inc.    222,643      42,587
  Simpson Manufacturing Co. Inc.    227,587      40,233
  AGCO Corp.    340,110      38,572
  Air Lease Corp.    575,883      37,219
  MSA Safety Inc.    202,172      35,815
  GATX Corp.    195,834      35,624
  UFP Industries Inc.    320,357      33,086
  Timken Co.    348,119      32,441
  Matson Inc.    171,227      27,448
  Mueller Water Products Inc. Class A    855,770      23,166
  Franklin Electric Co. Inc.    210,002      20,920
  Kadant Inc.     64,723      20,779
  Brady Corp. Class A    237,875      20,569
  Exponent Inc.    274,355      19,718
  HNI Corp.    378,699      18,098
  Griffon Corp.    215,824      17,579
  Standex International Corp.     67,560      16,214
  ABM Industries Inc.    340,391      15,672
  McGrath RentCorp.    135,206      15,101
  Hillenbrand Inc.    386,193      12,323
  CSG Systems International Inc.    150,231      11,981
  Alamo Group Inc.     59,297      11,581
4

 

Dividend Appreciation Index Fund
    Shares Market
Value

($000)
  Worthington Enterprises Inc.    172,454       9,583
  Insperity Inc.    198,523       8,483
  Tennant Co.     99,544       7,574
  Lindsay Corp.     59,407       7,442
  Gorman-Rupp Co.    113,746       6,198
  Apogee Enterprises Inc.    118,980       4,418
  Hyster-Yale Inc.     63,365       2,120
              14,134,086
Information Technology (25.9%)
  Broadcom Inc. 22,986,516   7,615,433
  Apple Inc. 18,238,748   4,732,590
  Microsoft Corp. 10,897,607   4,689,131
  Cisco Systems Inc. 21,645,945   1,695,310
  Lam Research Corp.  6,909,438   1,613,077
  International Business Machines Corp.  5,130,053   1,573,387
  Oracle Corp.  9,145,556   1,505,176
  Texas Instruments Inc.  4,997,113   1,077,128
  KLA Corp.    725,857   1,036,480
  Amphenol Corp. Class A  6,687,295     963,505
  Accenture plc Class A  3,400,394     896,480
  QUALCOMM Inc.  5,904,649     895,086
  Analog Devices Inc.  2,702,000     839,998
  Intuit Inc.  1,532,153     764,422
  Motorola Solutions Inc.    914,260     368,026
  TE Connectivity plc  1,618,883     360,655
  Microchip Technology Inc.  2,961,731     224,855
  Roper Technologies Inc.    590,817     219,329
  HP Inc.  5,273,493     102,517
  CDW Corp.    713,707      90,205
  Amdocs Ltd.    610,317      50,009
  Littelfuse Inc.    136,736      44,270
  Avnet Inc.    447,948      27,947
  Badger Meter Inc.    161,904      23,732
  Dolby Laboratories Inc. Class A    326,944      20,987
  Power Integrations Inc.    303,043      13,922
              31,443,657
Materials (3.2%)
  Linde plc  2,562,903   1,171,170
  Sherwin-Williams Co.  1,263,835     448,206
  Ecolab Inc.  1,399,068     394,523
  Air Products & Chemicals Inc.  1,220,929     332,703
  Nucor Corp.  1,256,011     223,218
  Vulcan Materials Co.    725,361     218,000
  PPG Industries Inc.  1,232,363     142,498
  Steel Dynamics Inc.    753,300     135,270
  Royal Gold Inc.    444,658     117,083
  Albemarle Corp.    645,817     110,196
  Reliance Inc.    286,948      94,549
  Avery Dennison Corp.    424,240      78,701
  RPM International Inc.    704,663      75,371
* Solstice Advanced Materials Inc.    871,404      53,827
  AptarGroup Inc.    360,515      45,046
  Eastman Chemical Co.    629,399      43,630
  Balchem Corp.    177,744      30,247
  Cabot Corp.    295,882      21,360
  Silgan Holdings Inc.    480,627      20,739
  Avient Corp.    503,785      18,212
  HB Fuller Co.    297,221      17,863
  Materion Corp.    113,758      15,730
  Hawkins Inc.    114,635      14,931
  Westlake Corp.    183,954      14,591
  Quaker Chemical Corp.     75,346      11,584
  Innospec Inc.    136,510      11,155
  Worthington Steel Inc.    178,390       7,177
  Stepan Co.    119,126       6,863
               3,874,443
Utilities (2.7%)
  NextEra Energy Inc. 11,430,160   1,004,711
  Sempra  3,582,334     311,699
5

 

Dividend Appreciation Index Fund
    Shares Market
Value

($000)
  Xcel Energy Inc.  3,247,256     246,986
  Entergy Corp.  2,451,193     235,045
  Public Service Enterprise Group Inc.  2,740,026     225,669
  DTE Energy Co.  1,139,015     153,061
  Ameren Corp.  1,467,813     151,596
  Atmos Energy Corp.    861,546     143,310
  American Water Works Co. Inc.  1,071,630     138,380
  CMS Energy Corp.  1,670,258     119,407
  NiSource Inc.  2,601,106     115,203
  Alliant Energy Corp.  1,410,221      92,948
  Essential Utilities Inc.  1,553,289      60,252
  National Fuel Gas Co.    500,324      41,902
  IDACORP Inc.    296,272      39,342
  TXNM Energy Inc.    537,355      31,661
  Otter Tail Corp.    229,940      20,501
  Chesapeake Utilities Corp.    129,923      16,718
  MGE Energy Inc.    200,569      16,021
  American States Water Co.    212,369      15,494
  California Water Service Group    327,043      14,619
  H2O America    183,092       9,528
  Middlesex Water Co.    101,171       5,299
  Unitil Corp.     98,174       4,998
  York Water Co.     79,294       2,663
               3,217,013
Total Common Stocks (Cost $74,053,907) 120,815,855
Temporary Cash Investments (0.5%)
Money Market Fund (0.5%)
1 Vanguard Market Liquidity Fund, 3.704% (Cost$591,434)  5,914,842            591,484
Total Investments (99.9%) (Cost $74,645,341) 121,407,339
Other Assets and Liabilities—Net (0.1%) 106,221
Net Assets (100%) 121,513,560
Cost is in $000.
See Note A in Notes to Financial Statements.
* Non-income-producing security.
1 Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
6

 

Dividend Appreciation Index Fund

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts
      ($000)
  Expiration Number of
Long (Short)
Contracts
Notional
Amount
Value and
Unrealized
Appreciation
(Depreciation)
Long Futures Contracts        
E-mini S&P 500 Index March 2026 448 156,033 671
    
Over-the-Counter Total Return Swaps
Reference Entity Termination
Date
Counterparty Notional
Amount
($000)
Floating
Interest Rate
Received
(Paid)1
(%)
Value and
Unrealized
Appreciation
($000)
Value and
Unrealized
(Depreciation)
($000)
Bank of America Corp. 2/1/2027 CITNA 51,390 (4.480) 1,028
Elevance Health Inc. 8/31/2026 BANA 4,223 (4.380) (351)
Goldman Sachs Group Inc. 8/31/2027 BANA 48,935 (4.480) 168
JPMorgan Chase & Co. 8/31/2027 BANA 171,290 (4.386) 2,697
Kroger Co. 2/1/2027 GSI 62,490 (3.630) 272
Visa Inc. Class A 8/31/2026 BANA 211,876 (3.620) (4,360)
          4,165 (4,711)
1 Based on Overnight Bank Funding Rate as of the most recent reset date. Floating interest payment received/(paid) monthly.
  BANA—Bank of America, N.A.
  CITNA—Citibank, N.A.
  GSI—Goldman Sachs International.
At January 31, 2026, the counterparties had deposited in segregated accounts securities with a value of $6,259 in connection with open over-the-counter swap contracts.
See accompanying Notes, which are an integral part of the Financial Statements.
7

 

Dividend Appreciation Index Fund
Statement of Assets and Liabilities
As of January 31, 2026
($000s, except shares and per-share amounts) Amount
Assets  
Investments in Securities, at Value  
Unaffiliated Issuers (Cost $74,053,907) 120,815,855
Affiliated Issuers (Cost $591,434) 591,484
Total Investments in Securities 121,407,339
Investment in Vanguard 2,838
Cash 28
Cash Collateral Pledged—Futures Contracts 10,250
Cash Collateral Pledged—Over-the-Counter Swap Contracts 750
Receivables for Investment Securities Sold 38,773
Receivables for Accrued Income 125,539
Receivables for Capital Shares Issued 9,682
Unrealized Appreciation—Over-the-Counter Swap Contracts 4,165
Total Assets 121,599,364
Liabilities  
Payables for Investment Securities Purchased 68,483
Payables for Capital Shares Redeemed 9,169
Payables to Vanguard 2,832
Variation Margin Payable—Futures Contracts 609
Unrealized Depreciation—Over-the-Counter Swap Contracts 4,711
Total Liabilities 85,804
Net Assets 121,513,560
At January 31, 2026, net assets consisted of:  
   
Paid-in Capital 79,142,713
Total Distributable Earnings (Loss) 42,370,847
Net Assets 121,513,560
 
ETF Shares—Net Assets  
Applicable to 460,176,681 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
103,085,375
Net Asset Value Per Share—ETF Shares $224.01
 
Admiral™ Shares—Net Assets  
Applicable to 303,134,223 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
18,428,185
Net Asset Value Per Share—Admiral Shares $60.79
  
See accompanying Notes, which are an integral part of the Financial Statements.
8

 

Dividend Appreciation Index Fund
Statement of Operations
  Year Ended
January 31, 2026
  ($000)
Investment Income  
Income  
Dividends1 1,943,482
Interest2 12,935
Securities Lending—Net 15
Total Income 1,956,432
Expenses  
The Vanguard Group—Note C  
Investment Advisory Services 2,256
Management and Administrative—ETF Shares 38,653
Management and Administrative—Admiral Shares 10,439
Marketing and Distribution—ETF Shares 3,278
Marketing and Distribution—Admiral Shares 769
Custodian Fees 376
Auditing Fees 33
Shareholders’ Reports and Proxy Fees—ETF Shares 2,599
Shareholders’ Reports and Proxy Fees—Admiral Shares 218
Trustees’ Fees and Expenses 67
Other Expenses 69
Total Expenses 58,757
Net Investment Income 1,897,675
Realized Net Gain (Loss)  
Investment Securities Sold2,3 2,916,656
Futures Contracts 10,324
Swap Contracts (35,700)
Realized Net Gain (Loss) 2,891,280
Change in Unrealized Appreciation (Depreciation)  
Investment Securities2 8,903,971
Futures Contracts (386)
Swap Contracts (38)
Change in Unrealized Appreciation (Depreciation) 8,903,547
Net Increase (Decrease) in Net Assets Resulting from Operations 13,692,502
1 Dividends are net of foreign withholding taxes of $181.
2 Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $12,556, $6, and $23, respectively. Purchases and sales are for temporary cash investment purposes.
3 Includes $3,465,543 of net gain (loss) resulting from in-kind redemptions.
  
See accompanying Notes, which are an integral part of the Financial Statements.
9

 

Dividend Appreciation Index Fund
Statement of Changes in Net Assets
  Year Ended January 31,
  2026
($000)
2025
($000)
Increase (Decrease) in Net Assets    
Operations    
Net Investment Income 1,897,675 1,739,775
Realized Net Gain (Loss) 2,891,280 2,966,914
Change in Unrealized Appreciation (Depreciation) 8,903,547 12,298,773
Net Increase (Decrease) in Net Assets Resulting from Operations 13,692,502 17,005,462
Distributions    
ETF Shares (1,611,638) (1,471,734)
Admiral Shares (284,573) (269,207)
Total Distributions (1,896,211) (1,740,941)
Capital Share Transactions    
ETF Shares 3,637,560 2,546,326
Admiral Shares 352,495 (37,347)
Net Increase (Decrease) from Capital Share Transactions 3,990,055 2,508,979
Total Increase (Decrease) 15,786,346 17,773,500
Net Assets    
Beginning of Period 105,727,214 87,953,714
End of Period 121,513,560 105,727,214
  
See accompanying Notes, which are an integral part of the Financial Statements.
10

 

Dividend Appreciation Index Fund
Financial Highlights
ETF Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $202.26 $172.53 $156.26 $162.69 $137.11
Investment Operations          
Net Investment Income1 3.560 3.381 3.185 2.982 2.736
Net Realized and Unrealized Gain (Loss) on Investments 21.748 29.728 16.293 (6.439) 25.504
Total from Investment Operations 25.308 33.109 19.478 (3.457) 28.240
Distributions          
Dividends from Net Investment Income (3.558) (3.379) (3.208) (2.973) (2.660)
Distributions from Realized Capital Gains
Total Distributions (3.558) (3.379) (3.208) (2.973) (2.660)
Net Asset Value, End of Period $224.01 $202.26 $172.53 $156.26 $162.69
Total Return 12.66% 19.34% 12.66% -2.02% 20.71%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $103,085 $89,405 $73,991 $66,062 $65,589
Ratio of Total Expenses to Average Net Assets 0.05% 0.06%2 0.06%2 0.06%2 0.06%
Ratio of Net Investment Income to Average Net Assets 1.72% 1.78% 1.99% 1.96% 1.74%
Portfolio Turnover Rate3 8% 11% 13% 12% 26%
1 Calculated based on average shares outstanding.
2 The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.06%.
3 Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund’s capital shares, including ETF Creation Units.
  
See accompanying Notes, which are an integral part of the Financial Statements.
11

 

Dividend Appreciation Index Fund
Financial Highlights
Admiral Shares          
For a Share Outstanding
Throughout Each Period 
Year Ended January 31,
2026 2025 2024 2023 2022
Net Asset Value, Beginning of Period $54.89 $46.82 $42.41 $44.15 $37.21
Investment Operations          
Net Investment Income1 .955 .907 .856 .801 .734
Net Realized and Unrealized Gain (Loss) on Investments 5.900 8.070 4.416 (1.743) 6.920
Total from Investment Operations 6.855 8.977 5.272 (.942) 7.654
Distributions          
Dividends from Net Investment Income (.955) (.907) (.862) (.798) (.714)
Distributions from Realized Capital Gains
Total Distributions (.955) (.907) (.862) (.798) (.714)
Net Asset Value, End of Period $60.79 $54.89 $46.82 $42.41 $44.15
Total Return2 12.63% 19.32% 12.64% -2.02% 20.67%
Ratios/Supplemental Data          
Net Assets, End of Period (Millions) $18,428 $16,322 $13,962 $12,471 $12,903
Ratio of Total Expenses to Average Net Assets 0.07% 0.08%3 0.08%3 0.08%3 0.08%
Ratio of Net Investment Income to Average Net Assets 1.70% 1.77% 1.97% 1.94% 1.72%
Portfolio Turnover Rate4 8% 11% 13% 12% 26%
1 Calculated based on average shares outstanding.
2 Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3 The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.08%.
4 Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund’s capital shares, including ETF Creation Units.
  
See accompanying Notes, which are an integral part of the Financial Statements.
12

 

Dividend Appreciation Index Fund
Notes to Financial Statements
Vanguard Dividend Appreciation Index Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: ETF Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors. ETF Shares are listed for trading on NYSE Arca; they can be purchased and sold through a broker.
A. The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund’s pricing time but after the close of the securities’ primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value.
2. Futures Contracts: The fund uses index futures contracts to a limited extent, with the objectives of maintaining full exposure to the stock market, maintaining liquidity, and minimizing transaction costs. The fund may purchase futures contracts to immediately invest incoming cash in the market, or sell futures in response to cash outflows, thereby simulating a fully invested position in the underlying index while maintaining a cash balance for liquidity. The primary risks associated with the use of futures contracts are imperfect correlation between changes in market values of stocks held by the fund and the prices of futures contracts, and the possibility of an illiquid market. Counterparty risk involving futures is mitigated because a regulated clearinghouse is the counterparty instead of the clearing broker. To further mitigate counterparty risk, the fund trades futures contracts on an exchange, monitors the financial strength of its clearing brokers and clearinghouse, and has entered into clearing agreements with its clearing brokers. The clearinghouse imposes initial margin requirements to secure the fund’s performance and requires daily settlement of variation margin representing changes in the market value of each contract. Any securities pledged as initial margin for open contracts are noted in the Schedule of Investments.
Futures contracts are valued at their quoted daily settlement prices. The notional amounts of the contracts are not recorded in the Statement of Assets and Liabilities. Fluctuations in the value of the contracts are recorded in the Statement of Assets and Liabilities as an asset (liability) and in the Statement of Operations as unrealized appreciation (depreciation) until the contracts are closed, when they are recorded as realized gains (losses) on futures contracts.
During the year ended January 31, 2026, the fund’s average investments in long and short futures contracts represented less than 1% and 0% of net assets, respectively, based on the average of the notional amounts at each quarter-end during the period.
3.  Swap Contracts: The fund has entered into equity swap contracts to earn the total return on selected reference stocks or indexes in the fund’s target index. Under the terms of the swaps, the fund receives the total return on the referenced stock (i.e., receiving the increase or paying the decrease in value of the selected reference stock and receiving the equivalent of any dividends in respect of the selected referenced stock) over a specified period of time, applied to a notional amount that represents the value of a designated number of shares of the selected reference stock at the beginning of the equity swap contract. The fund also pays a floating rate that is based on short-term interest rates, applied to the notional amount. At the same time, the fund generally invests an amount approximating the notional amount of the swap in high-quality temporary cash investments.
A risk associated with all types of swaps is the possibility that a counterparty may default on its obligation to pay net amounts due to the fund. The fund’s maximum amount subject to counterparty risk is the unrealized appreciation on the swap contract. The fund mitigates its counterparty risk by entering into swaps only with a diverse group of prequalified counterparties, monitoring their financial strength, entering into master netting arrangements with its counterparties, and requiring its counterparties to transfer collateral as security for their performance. In the absence of a default, the collateral pledged or received by the fund cannot be repledged, resold, or rehypothecated. In the event of a counterparty’s default (including bankruptcy), the fund may terminate any swap contracts with that counterparty, determine the net amount owed by either party in accordance with its master netting arrangements, and sell or retain any collateral held up to the net amount owed to the fund under the master netting arrangements. The swap contracts contain provisions whereby a counterparty may terminate open contracts if the fund’s net assets decline below a certain level, triggering a payment by the fund if the fund is in a net liability position at the time of the termination. The payment amount would be reduced by any collateral the fund has pledged. Any securities pledged as collateral for open contracts are noted in the Schedule of Investments. The value of collateral received or pledged is compared daily to the value of the swap contracts exposure with each counterparty, and any difference, if in excess of a specified minimum transfer amount, is adjusted and settled within two business days.
The notional amounts of swap contracts are not recorded in the Statement of Assets and Liabilities. Swaps are valued daily based on market quotations received from independent pricing services or recognized dealers and the change in value is recorded in the Statement of Assets and Liabilities as an asset (liability) and in the Statement of Operations as unrealized appreciation (depreciation) until periodic payments are made or the termination of the swap, at which time realized gain (loss) is recorded.
During the year ended January 31, 2026, the fund’s average amounts of investments in total return swaps represented less than 1% of net assets, based on the average of notional amounts at each quarter-end during the period.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund’s tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund’s tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund’s financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
13

 

Dividend Appreciation Index Fund
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty’s default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund’s regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund’s board of trustees and included in Management and Administrative expenses on the fund’s Statement of Operations. Any borrowings under either facility bear interest at an agreed-upon spread plus the higher of the federal funds effective rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate inclusive of an additional agreed-upon spread. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the “Order”) from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund’s investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day’s notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the year ended January 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund is accrued daily. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses), shareholder reporting, and proxy fees. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B. Vanguard provides investment advisory services to the fund through its wholly owned subsidiary Vanguard Portfolio Management, LLC.
C. In accordance with the terms of a Funds' Service Agreement (the “FSA”) between Vanguard and the fund, Vanguard furnishes to the fund investment advisory, corporate management, administrative, marketing, and distribution services at Vanguard’s cost of operations (as defined by the FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At January 31, 2026, the fund had contributed to Vanguard capital in the amount of $2,838,000, representing less than 0.01% of the fund’s net assets and 1.14% of Vanguard’s capital received pursuant to the FSA. The fund’s trustees and officers are also directors and employees, respectively, of Vanguard.
D. Various inputs may be used to determine the value of the fund’s investments and derivatives. These inputs are summarized in three broad levels for financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in those securities.
Level 1—Quoted prices in active markets for identical securities.
Level 2—Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3—Significant unobservable inputs (including the fund’s own assumptions used to determine the fair value of investments). Any investments and derivatives valued with significant unobservable inputs are noted on the Schedule of Investments.
14

 

Dividend Appreciation Index Fund
The following table summarizes the market value of the fund’s investments and derivatives as of January 31, 2026, based on the inputs used to value them:
  Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments        
Assets        
Common Stocks 120,815,855 120,815,855
Temporary Cash Investments 591,484 591,484
Total 121,407,339 121,407,339
Derivative Financial Instruments        
Assets        
Futures Contracts1 671 671
Swap Contracts 4,165 4,165
Total 671 4,165 4,836
Liabilities        
Swap Contracts (4,711) (4,711)
1 Includes cumulative appreciation (depreciation) on futures contracts and centrally cleared swaps, if any, as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statement of Assets and Liabilities.
E. Permanent differences between book-basis and tax-basis components of net assets are reclassified among capital accounts in the financial statements to reflect their tax character. These reclassifications have no effect on net assets or net asset value per share. Examples of permanent differences include, but are not limited to, the accounting for passive foreign investment companies, in-kind redemptions, swap agreements, and distributions in connection with fund share redemptions.
Permanent differences were reclassified between the following accounts: Amount
($000)
Paid-in Capital 3,465,109
Total Distributable Earnings (Loss) (3,465,109)
Temporary differences between book-basis and tax-basis components of total distributable earnings (loss) arise when certain items of income, gain, or loss are recognized in different periods for financial statement and tax purposes; these differences will reverse at some time in the future. Examples of temporary differences include, but are not limited to, capital loss carryforwards, the deferral of losses from wash sales, the recognition of unrealized gains or losses from certain derivative contracts, and the recognition of unrealized gains from passive foreign investment companies. As of period end, the tax-basis components of total distributable earnings (loss) are detailed in the table as follows:
  Amount
($000)
Undistributed Ordinary Income 128,811
Undistributed Long-Term Gains
Net Unrealized Gains (Losses) 46,707,440
Capital Loss Carryforwards (4,465,404)
Qualified Late-Year Losses
Other Temporary Differences
Total 42,370,847
The tax character of distributions paid was as follows:
  Year Ended January 31,
  2026
Amount
($000)
2025
Amount
($000)
Ordinary Income* 1,896,211 1,740,941
Long-Term Capital Gains
Total 1,896,211 1,740,941
* Includes short-term capital gains, if any.
15

 

Dividend Appreciation Index Fund
As of January 31, 2026, gross unrealized appreciation and depreciation for investments and derivatives based on cost for U.S. federal income tax purposes were as follows:
  Amount
($000)
Tax Cost 74,699,899
Gross Unrealized Appreciation 48,297,595
Gross Unrealized Depreciation (1,590,155)
Net Unrealized Appreciation (Depreciation) 46,707,440
F. During the year ended January 31, 2026, the fund purchased $9,279,496,000 of investment securities and sold $9,040,226,000 of investment securities, other than temporary cash investments. In addition, the fund purchased and sold investment securities of $10,770,856,000 and $7,385,443,000, respectively, in connection with in-kind purchases and redemptions of the fund's capital shares.
The fund purchased securities from and sold securities to other Vanguard funds or accounts managed by Vanguard or its affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the year ended January 31, 2026, such purchases were $1,351,783,000 and sales were $1,348,926,000, resulting in net realized loss of $177,092,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
G. Capital share transactions for each class of shares were:
    
  Year Ended January 31,
  2026   2025
  Amount
($000)
Shares
(000)
  Amount
($000)
Shares
(000)
ETF Shares          
Issued 11,071,909 54,943   8,816,447 47,080
Issued in Lieu of Cash Distributions  
Redeemed (7,434,349) (36,800)   (6,270,121) (33,900)
Net Increase (Decrease)—ETF Shares 3,637,560 18,143   2,546,326 13,180
Admiral Shares          
Issued 2,704,097 47,722   1,897,356 37,100
Issued in Lieu of Cash Distributions 239,326 4,241   227,893 4,435
Redeemed (2,590,928) (46,202)   (2,162,596) (42,360)
Net Increase (Decrease)—Admiral Shares 352,495 5,761   (37,347) (825)
H. Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse impact on the value of the fund’s investments and fund performance.
To the extent the fund’s investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
The use of derivatives may expose the fund to various risks. Derivatives can be highly volatile, and any initial investment is generally small relative to the notional amount so that transactions may be leveraged in terms of market exposure. A relatively small market movement may have a potentially larger impact on derivatives than on standard securities. Leveraged derivatives positions can, therefore, increase volatility. Additional information regarding the fund’s use of derivative(s) and the specific risks associated is described under significant accounting policies.
I. Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their operating results regularly reviewed by a chief operating decision maker (“CODM”). The fund is considered a single segment. Vanguard’s chief executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund’s chief financial officer collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund’s daily operations. Through these committees, the CODM manages the fund’s operations to achieve a single investment objective, as detailed in its prospectus, through the execution of the fund’s investment strategies. When assessing segment performance and making decisions about segment resources, the CODM relies on the fund’s portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the information contained in the fund’s financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying financial statements.
J. Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would require recognition or disclosure in these financial statements.
16

 

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of Vanguard Specialized Funds and Shareholders of Vanguard Dividend Appreciation Index Fund
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of Vanguard Dividend Appreciation Index Fund (one of the funds constituting Vanguard Specialized Funds, referred to hereafter as the "Fund") as of January 31, 2026, the related statement of operations for the year ended January 31, 2026, the statement of changes in net assets for each of the two years in the period ended January 31, 2026, including the related notes, and the financial highlights for each of the five years in the period ended January 31, 2026 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of January 31, 2026, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended January 31, 2026 and the financial highlights for each of the five years in the period ended January 31, 2026 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of January 31, 2026 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 20, 2026
We have served as the auditor of one or more investment companies in The Vanguard Group of Funds since 1975.
17

 


Tax information (unaudited)
For corporate shareholders, 97.8%, or if subsequently determined to be different, the maximum percentage allowable by law, of ordinary income (dividend income plus short-term gains, if any) for the fiscal year qualified for the dividends-received deduction.
The fund hereby designates $1,896,211,000, or if subsequently determined to be different, the maximum amount allowable by law, as qualified dividend income for purposes of the maximum rate under section 1(h)(11) for calendar year 2025.
The fund hereby designates for the fiscal year $6,913,000, or if subsequently determined to be different, the maximum amount allowable by law, of interest earned from obligations of the U.S. government which is generally exempt from state income tax.
Q6020 032026
18

 

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

 

Not applicable.

 

Item 9: Proxy Disclosures for Open-End Management Investment Companies.

 

Not applicable.

 

Item 10: Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

 

Not applicable. The Trustees’ Fees and Expenses are included in the financial statements filed under Item 7 of this Form.

 

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contracts.

 

Trustees Approve Advisory Arrangement - Dividend Growth Fund

 

A majority of independent trustees of the board of Vanguard Dividend Growth Fund have renewed the fund’s investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The trustees determined that renewing the fund’s advisory arrangement was in the best interests of the fund and its shareholders.

 

The trustees based their decision upon an evaluation of the advisor’s investment staff, portfolio management process, and performance. This evaluation included information provided to the trustees by Vanguard’s Oversight and Manager Search team (OMS), which is responsible for fund and advisor oversight and product management. OMS met regularly with the advisor and made presentations to the trustees during the fiscal year that directed their focus to relevant information and topics.

 

The trustees also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor’s assessment of the investment environment, portfolio performance, and portfolio characteristics.

 

In addition, the trustees received periodic reports throughout the year, which included information about each fund’s performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team’s ongoing assessment of the advisor.

 

Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the trustees approved the arrangement. Rather, it was the totality of the circumstances that drove the trustees’ decision.

 

 

 

 

Nature, extent, and quality of services

 

The trustees reviewed the quality of the fund’s investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The trustees considered that Wellington Management, founded in 1928, is among the nation’s oldest and most respected institutional managers. The trustees also noted that the portfolio manager of the fund has nearly three decades of industry experience. Wellington Management seeks to invest in companies with a history of paying a stable or growing dividend and the ability to continue increasing their dividend over the long term. Utilizing fundamental research, Wellington Management focuses on a company’s ability to create value and the ability and willingness to distribute that value to shareholders in a sustainable manner. Valuation is also an important input to the investment process, as the advisor seeks to purchase these businesses when short-term dislocations have made the share price attractive. Wellington Management has advised the fund since its inception in 1992.

 

The trustees concluded that Wellington Management’s experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.

 

Investment performance

 

The trustees considered the fund’s performance since its inception in 2017, including any periods of outperformance or underperformance of a relevant benchmark. The trustees concluded the performance was such that the advisory arrangement should continue.

 

Cost

 

The trustees concluded that the fund’s expense ratio was below the average expense ratio charged by funds in its peer group and that the fund’s advisory fee rate was also below the peer-group average.

 

The trustees did not consider the profitability of Wellington Management in determining whether to approve the advisory fee, because Wellington Management is independent of Vanguard and the advisory fee is the result of arm’s-length negotiations.

 

The benefit of economies of scale

 

The trustees concluded that the fund’s shareholders benefit from economies of scale because of breakpoints in the fund’s advisory fee schedule. The breakpoints reduce the effective rate of the fee as the fund’s assets increase.

 

The trustees will consider whether to renew the advisory arrangement again after a one-year period.

 

Trustees Approve Advisory Arrangements - Dividend Appreciation Index Fund

 

A majority of independent trustees of the board of Vanguard Dividend Appreciation Index Fund (Trustees) have approved a restructuring of each fund’s management structure whereby the Vanguard Group, Inc. (Vanguard) will now provide investment advisory services to the fund through its subsidiary, Vanguard Portfolio Management LLC (VPM). The trustees determined that approving the advisory arrangements was in the best interests of each fund and its shareholders.

 

 

 

 

The Trustees based their decisions upon an evaluation of VPM’s investment staff, portfolio management process, and performance. This evaluation included information provided by Vanguard’s Oversight and Manager Search team, which is responsible for fund and advisor oversight and product management. The Trustees considered the factors discussed below, among others. However, no single factor determined whether to approve the arrangement. Rather, it was the totality of the circumstances that drove the Trustee’s decisions.

 

Nature, extent, and quality of services

 

The Trustees considered the quality of the investment management services to be provided to the funds and took into account the organizational depth and stability of Vanguard and VPM. The Trustees considered that Vanguard has been managing investments for more than four decades. The Strategic Equity Index Management team (SE), now within VPM, adheres to the same sound, disciplined investment management process and has considerable experience, stability and depth. In its management of other Vanguard passive and active equity funds and portfolios, the team has a track record of consistent performance as a result of its disciplined investment processes. SE has specific expertise and experience managing U.S. style-box, sector, and smart-beta index strategies, effectively navigating index reconstitutions and mitigating transactions costs to deliver tight tracking error while opportunistically seeking to add excess returns through sophisticated trading strategies and superior access to corporate actions.

 

The Trustees concluded that VPM’s experience, stability, depth, and performance, among other factors, warranted approval of the advisory arrangements.

 

Investment performance

 

The Trustees determined that VPM’s Strategic Equity Index Management team, in its management of Vanguard funds, including the funds, has a track record of consistent performance and disciplined investment processes.

 

Cost

 

The Trustees concluded that each fund’s expense ratio will remain below the average expense ratio charged by funds in its peer group and that each fund’s advisory expenses will also continue to be below the peer-group average.

 

The Trustees do not conduct a profitability analysis of Vanguard in providing investment advisory services through VPM because of Vanguard’s unique structure. Unlike most other mutual fund management companies, Vanguard is owned by the funds it oversees.

 

The benefit of economies of scale

 

The Trustees concluded that each fund’s arrangement with Vanguard, and services rendered through VPM, ensure that each fund will realize economies of scale as it grows, with the cost to shareholders declining as fund assets increase.

 

The Trustees will consider whether to renew the advisory arrangements again after a one-year period.

 

 

 

 

Item 12: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

 

Not applicable.

 

Item 13: Portfolio Managers of Closed-End Management Investment Companies.

 

Not applicable.

 

Item 14: Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

 

Not applicable.

 

Item 15: Submission of Matters to a Vote of Security Holders.

 

Not applicable.

 

Item 16: Controls and Procedures.

 

(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

 

(b) Internal Control Over Financial Reporting. There were no changes in the Registrant’s Internal Control Over Financial Reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

Item 17: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

 

Not applicable.

 

Item 18: Recovery of Erroneously Awarded Compensation

 

Not applicable.

 

Item 19: Exhibits.

 

(a)(1) Code of Ethics filed herewith.
(a)(2) Certifications filed herewith.
(a)(2) Certifications filed herewith.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  VANGUARD SPECIALIZED FUNDS
     
BY: /s/ SALIM RAMJI*  
     
  SALIM RAMJI  
  CHIEF EXECUTIVE OFFICER  

 

Date: March 24, 2026

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

  VANGUARD SPECIALIZED FUNDS
     
BY: /s/ SALIM RAMJI*  
     
  SALIM RAMJI  
  CHIEF EXECUTIVE OFFICER  

 

Date: March 24, 2026

 

  VANGUARD SPECIALIZED FUNDS
     
BY: /s/ CHRISTINE BUCHANAN*
   
  CHRISTINE BUCHANAN  
  CHIEF FINANCIAL OFFICER  

 

Date: March 24, 2026

 

* By: /s/ Natalie Lamarque  

 

Natalie Lamarque, pursuant to a Power of Attorney  filed on December 19, 2025 (see File Number 33-49023), and to a Power of Attorney  filed on February 27, 2026 (see File Number 333-177613), Incorporated by Reference.

 

 

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 99.CODEETH

EXHIBIT 99.CERT

EXHIBIT 99.906CERT

XBRL TAXONOMY EXTENSION SCHEMA

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: tm265717d4_ncsr_htm.xml